{"study_id": 68230, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the potential of myo-inositol, among other nutritional supplements, for the prevention or treatment of gestational diabetes mellitus (GDM).", "results_summary": "The study found limited evidence suggesting myo-inositol might be beneficial for glycemic control or GDM prevention, but results were inconsistent and based on few, small-scale studies.", "population_specificity": "Pregnant women at risk of or diagnosed with gestational diabetes mellitus (GDM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:42.465512+00:00"}
{"study_id": 68232, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Inositol supplementation (Trazer F Forte) in women with polycystic ovarian syndrome (PCOS).", "results_summary": "The abstract does not provide specific results regarding Inositol's effects, but the study was conducted to assess its impact on PCOS-related conditions such as insulin resistance and hyperandrogenism.", "population_specificity": "Women with polycystic ovarian syndrome (PCOS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:42.758090+00:00"}
{"study_id": 68229, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the roles of fungal inositol polyphosphate kinases (IPKs) and their products in fungal pathogenicity, with potential implications for antifungal drug development.", "results_summary": "The abstract highlights that fungal IPKs and their inositol polyphosphate products play a role in fungal pathogenicity, suggesting they could be targets for novel antifungal therapies. However, specific results regarding efficacy or safety of inositol itself are not provided.", "population_specificity": "Model fungal pathogens (specific species not detailed in the abstract).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:43.099037+00:00"}
{"study_id": 68228, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of urinary inositol phosphoglycans P-type (IPG-P) as a noninvasive screening test for preeclampsia.", "results_summary": "The meta-analysis found that IPG-P demonstrated high sensitivity (0.82-0.99) and specificity (0.90-1.00) in identifying women who would develop preeclampsia, with strong diagnostic accuracy measures. However, the studies were limited by being conducted by a single academic group across different settings.", "population_specificity": "Pregnant women at risk for or diagnosed with preeclampsia in the UK, Italy, France, South Africa, and Mauritius.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:43.933029+00:00"}
{"study_id": 68227, "supplement_id": 1223, "safety_score": "85", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the safety, tolerability, and efficacy of SNF472 (a formulation of myo-inositol hexaphosphate) in improving wound healing, pain, and quality of life in calciphylaxis patients on hemodialysis.", "results_summary": "SNF472 showed significant improvements in wound healing (BWAT score), pain reduction (VAS), and quality of life (wound-QoL) over 12 weeks. The treatment was well-tolerated with no serious adverse events attributed to SNF472.", "population_specificity": "End-stage renal disease patients with calciphylaxis on thrice-weekly hemodialysis.", "effective_dosage": "Intravenous SNF472 3 times per week (specific dose not detailed in abstract).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:44.095251+00:00"}
{"study_id": 68235, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of seven different ratios of myo-inositol (MI) and D-chiro-inositol (DCI) in treating polycystic ovary syndrome (PCOS), focusing on ovulation restoration and hormonal parameter normalization.", "results_summary": "The study found that a 40:1 MI/DCI ratio was most effective for restoring ovulation and improving hormonal and metabolic parameters in PCOS patients, while other ratios, especially those favoring DCI, showed reduced efficacy.", "population_specificity": "56 PCOS patients (8 per treatment group).", "effective_dosage": "2 g of inositols twice a day.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:50.683801+00:00"}
{"study_id": 68239, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were summarizing discoveries about Bcl-2's role in the normal immune system and its aberrant elevation in cancers, particularly those arising from immune cells.", "results_summary": "The abstract does not mention Inositol or its effects; it focuses on Bcl-2's role in immune regulation and cancer.", "population_specificity": "Not specified (abstract discusses immune system cells and cancers broadly).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:51.320565+00:00"}
{"study_id": 68241, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to summarize consensus guidelines for flow cytometric detection of PNH clones in RBC and WBC, focusing on diagnosis, monitoring, and clinical management of PNH.", "results_summary": "The study highlights the role of flow cytometry as the gold standard for detecting PNH clones and summarizes key aspects of international consensus guidelines for assay validation and reporting.", "population_specificity": "Patients with paroxysmal nocturnal hemoglobinuria (PNH).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:51.444595+00:00"}
{"study_id": 68234, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of myo-inositol (MYO), alpha-lipoic acid (ALA), and their combination on hormonal and metabolic parameters in overweight/obese patients with polycystic ovary syndrome (PCOS).", "results_summary": "MYO improved hormonal profiles and glucose tolerance in PCOS patients without familial diabetes, while ALA enhanced insulin response and metabolic parameters without affecting reproductive hormones. The combination of MYO and ALA improved both hormonal and metabolic aspects, including insulin response, in all PCOS patients regardless of familial diabetes.", "population_specificity": "Overweight/obese patients with polycystic ovary syndrome (PCOS), including those with and without familial diabetes.", "effective_dosage": "MYO (1 g/day), ALA (400 mg/day), or MYO (1 g/day) + ALA (400 mg/day) orally.", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:51.620337+00:00"}
{"study_id": 68236, "supplement_id": 1223, "safety_score": "70", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to assess the effectiveness and safety of supplementary inositol in preterm infants with or without respiratory distress syndrome (RDS) in reducing adverse neonatal outcomes.", "results_summary": "Inositol supplementation did not significantly reduce infant deaths, severe ROP, IVH grades 3 or 4, BPD, NEC, or sepsis. Neonatal death was reduced in some trials, but a larger study showed higher mortality in the inositol group.", "population_specificity": "Preterm infants, particularly those born at less than 30 weeks' postmenstrual age (PMA).", "effective_dosage": "80 mg/kg/day (in one comparison).", "study_duration": "Varied across trials; not explicitly stated in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:52.021325+00:00"}
{"study_id": 68237, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to elucidate the role of SELENOK in palmitoylation of the inositol 1,4,5-trisphosphate receptor (IP3R) and its implications for calcium flux in immune cells and melanoma progression.", "results_summary": "The study found that SELENOK/DHHC6 complex palmitoylates IP3R, stabilizing the calcium channel and enhancing calcium flux, which is critical for immune cell activation and melanoma progression. Lower SELENOK levels impair IP3R-driven calcium flux, suggesting a potential therapeutic target for cancers like melanoma.", "population_specificity": "Knockout mice and genetically manipulated cell lines.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:52.507091+00:00"}
{"study_id": 68242, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of inositol metabolism in bipolar disorder, particularly its connection to intracellular calcium signaling and neuronal hyperexcitability.", "results_summary": "The study suggests that inositol metabolism is implicated in bipolar disorder through its involvement in intracellular calcium signaling, which may lead to neuronal hyperexcitability. Genetic and cellular studies support this mechanism, with potential links to mitochondrial dysfunction and oxidative stress.", "population_specificity": "Not specified (general focus on bipolar disorder mechanisms).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:52.679995+00:00"}
{"study_id": 68240, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to examine the signaling mechanisms of 5-HT1A receptors in regulating serotonin activity and behavior, including their role in synaptogenesis, cell survival, and antidepressant effects.", "results_summary": "The study found that 5-HT1A receptors exhibit cell-specific signaling, influencing neuronal activity, synaptogenesis, and antidepressant actions through various pathways, with differential desensitization between autoreceptors and heteroreceptors.", "population_specificity": "Not specified (focus on neuronal mechanisms in vitro and in vivo models).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:53.427491+00:00"}
{"study_id": 68244, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of inositols on anti-Mullerian hormone, antral follicle count, and reproductive outcomes in women with polycystic ovary syndrome undergoing IVF/ICSI.", "results_summary": "The study found no consistent evidence of inositols affecting ovarian reserve markers or improving reproductive outcomes, with no significant differences observed in oocyte count, embryo quality, clinical pregnancy rate, or risk of ovarian hyperstimulation syndrome. The quality of evidence was assessed as very low.", "population_specificity": "Women with polycystic ovary syndrome undergoing IVF/ICSI.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:59.610137+00:00"}
{"study_id": 68245, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to examine strategies for plasmalogen modulation, including dietary intervention with inositol, and its therapeutic potential in neurodegenerative and cardiometabolic diseases.", "results_summary": "The study suggests that inositol, as a dietary intervention, may help upregulate plasmalogen levels, potentially attenuating progression of neurodegenerative diseases, atherosclerosis, insulin resistance, and hepatosteatosis. However, mechanistic bases and specific outcomes of inositol supplementation are not detailed.", "population_specificity": "Not specified (broad focus on neurodegenerative and cardiometabolic diseases).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:59.683429+00:00"}
{"study_id": 68246, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the roles of apoptosis, autophagy, and unfolded protein response (UPR) in cellular responses to viral infections, including arboviruses, influenza virus, and HIV.", "results_summary": "The abstract discusses the involvement of apoptosis, autophagy, and UPR in regulating cellular responses to viral infections but does not provide specific findings related to Inositol.", "population_specificity": "Not specified (focus on cellular responses in general).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:07:59.950386+00:00"}
{"study_id": 68247, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of scyllo-inositol as a novel agent for treating behavioral and psychological symptoms associated with dementia.", "results_summary": "The study highlighted scyllo-inositol as a promising agent for treating behavioral and psychological symptoms of dementia, demonstrating efficacy and generally good tolerability. However, detailed results specific to scyllo-inositol were not provided in the abstract.", "population_specificity": "Individuals with behavioral and psychological symptoms associated with dementia.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:00.228709+00:00"}
{"study_id": 68243, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the association between long-term calcineurin inhibitor (CNI) therapy after liver transplantation and alterations in brain metabolites, including myo-inositol.", "results_summary": "The study found that myo-inositol levels were significantly lower in CNI-free patients compared to controls and patients on low-dose or standard-dose CNI therapy, suggesting CNI therapy may influence myo-inositol metabolism.", "population_specificity": "Patients 10 years post-liver transplantation, including CNI-free, low-dose CNI, and standard-dose CNI groups, compared to healthy controls.", "effective_dosage": "Not specified for inositol; CNI doses varied (low-dose and standard-dose).", "study_duration": "Long-term (10 years post-transplant).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:00.934711+00:00"}
{"study_id": 68250, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to review the efficacy of various drugs, including inositol, in treating impulse-control disorders such as trichotillomania, excoriation disorder, and nail-biting.", "results_summary": "The study mentions inositol as one of the drugs used in the treatment of trichotillomania, but it does not provide specific efficacy data or outcomes for inositol alone. The overall conclusion suggests that treatment outcomes for these disorders remain disappointing.", "population_specificity": "Patients with trichotillomania, excoriation disorder, or severe nail-biting.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:01.991988+00:00"}
{"study_id": 68248, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of myo-Inositol on oocyte quality, fertilization rate, and embryo quality in PCOS patients undergoing assisted reproductive technology (ART) cycles.", "results_summary": "The study found that myo-Inositol significantly improved metaphase II oocyte percentage, fertilization rate, and embryo quality, along with increased gene expression of PGK1, RGS2, and CDC42 in granulosa cells, but did not affect the number of retrieved oocytes, follicle count, or antioxidant/ROS levels.", "population_specificity": "50 infertile PCOS patients undergoing ART cycles.", "effective_dosage": "4 g myo-Inositol combined with 400 mg folic acid daily.", "study_duration": "From 1 month before starting the antagonist cycle until the day of ovum pick-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:02.342618+00:00"}
{"study_id": 68249, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the clinical benefits of three treatment modalities (diet alone, diet with myo-inositol, and diet with a combination of myo-inositol and D-chiroinositol) in overweight/obese women with PCOS.", "results_summary": "All groups showed significant reductions in body weight, BMI, and waist/hip circumferences. The combination of MI+DCI with diet was most effective in restoring menstrual regularity and accelerating weight loss and fat mass reduction.", "population_specificity": "Overweight/obese women with polycystic ovary syndrome (PCOS).", "effective_dosage": "Group 2: MI 4 g + folic acid 400 \u00b5g daily; Group 3: MI 1.1 g + DCI 27.6 mg + folic acid 400 \u00b5g daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:03.167590+00:00"}
{"study_id": 68253, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the therapeutic efficacy of belinostat, an HDAC inhibitor, and its impact on myo-inositol levels in the context of glioma treatment and depression.", "results_summary": "Belinostat reduced tumor volume in a rat glioma model and improved depressive symptoms in animal models and human patients. Myo-inositol levels were also improved by belinostat treatment in vitro.", "population_specificity": "Orthotopic rat glioma models, animal models of depression, and human patients with glioblastoma.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:08.114372+00:00"}
{"study_id": 68251, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the effects of inositol and antioxidant-based supplements on pregnancy complicated by insulin resistance and/or diabetes.", "results_summary": "The study suggests that inositol and antioxidants exhibit insulin-sensitizing, anti-inflammatory, and antioxidant properties, potentially improving glucose metabolism and maternal-fetal outcomes in diabetic pregnancies. However, the abstract does not provide specific quantitative results or statistical significance.", "population_specificity": "Pregnant individuals with insulin resistance and/or diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:08.807238+00:00"}
{"study_id": 68254, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of myo-inositol and metformin in improving ovarian function and pregnancy rates in infertile women with PCOS treated with letrozole.", "results_summary": "Inositol improved ovarian function more than metformin in women with normal BMI, but pregnancy rates were not significantly different between groups. Ovarian function also improved with longer infertility duration in the inositol group.", "population_specificity": "150 infertile women with PCOS and letrozole resistance.", "effective_dosage": "2 g inositol plus 200 \u00b5g folic acid twice daily.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:09.055992+00:00"}
{"study_id": 68256, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of ER stress modulation by natural compounds, including inositol, in exerting anticancer effects.", "results_summary": "The abstract does not provide specific findings on inositol but discusses the broader role of ER stress in the cytotoxicity of natural compounds like curcumin, resveratrol, and others.", "population_specificity": "Human cancers (broadly mentioned, no specific population detailed).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:09.890452+00:00"}
{"study_id": 68252, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to analyze the characteristics of PNH clones, their association with clinical syndromes, and changes during follow-up, focusing on glycosyl-phosphatidyl-inositol-anchor deficiencies.", "results_summary": "The study found two distinct patterns of Type3 PNH clone sizes, with small clones associated with bone marrow failure and large clones linked to hemolysis and thrombosis. It also documented changes in clone size over follow-up and variations in cellular composition.", "population_specificity": "529 patients with paroxysmal nocturnal hemoglobinuria (PNH), including 34 pediatric cases.", "effective_dosage": "Not available", "study_duration": "Follow-up retesting over 1 year in 151 cases.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:10.005084+00:00"}
{"study_id": 68255, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to identify gender-specific fecal metabolite signatures in ankylosing spondylitis (AS) patients, including the role of D-myo-Inositol in female AS patients.", "results_summary": "The study found that D-myo-Inositol was a female-specific fecal signature in AS patients, suggesting a potential gender-specific metabolic role in AS. No direct efficacy or mechanistic outcomes of Inositol were reported.", "population_specificity": "87 cross-sectional individuals (healthy controls: 20 males, 18 females; AS patients: 26 males, 23 females).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:10.469690+00:00"}
{"study_id": 68259, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize age-associated neurometabolite changes, particularly Myo-inositol (mI), and their associations with cognition in non-clinical populations using proton MRS.", "results_summary": "The study found that Myo-inositol (mI) concentration increased with age in the posterior cingulate cortex (PCC), mirroring changes often seen in Alzheimer disease. These findings suggest a potential link between mI levels and cognitive aging.", "population_specificity": "Non-clinical (healthy) aging populations.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:10.903887+00:00"}
{"study_id": 68258, "supplement_id": 1223, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to assess the safety, tolerability, and pharmacokinetics/pharmacodynamics of intravenous SNF472 (a calcification inhibitor) in hemodialysis patients, as well as its potential to inhibit hydroxyapatite formation.", "results_summary": "SNF472 was found to be safe and well-tolerated in hemodialysis patients, with no clinically relevant adverse effects. It demonstrated dose-dependent inhibition of hydroxyapatite crystallization (78% inhibition at 10 mg/kg after 28 days).", "population_specificity": "Hemodialysis patients", "effective_dosage": "1 to 20 mg/kg (Cohort 1), 10 mg/kg (Cohort 2), administered intravenously", "study_duration": "1 week (Cohort 1), 4 weeks (Cohort 2)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:12.318192+00:00"}
{"study_id": 68260, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of Metformin plus Myo-inositol versus Metformin alone in improving fertility outcomes in infertile women with PCOS.", "results_summary": "The combination of Metformin and Myo-inositol significantly improved menstrual cycles and live birth rates compared to Metformin alone, though hormonal and biochemical improvements were similar between groups.", "population_specificity": "Infertile women with polycystic ovarian syndrome (PCOS).", "effective_dosage": "600 mg Myo-inositol three times a day.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:16.726560+00:00"}
{"study_id": 68262, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with PCOS.", "results_summary": "Myo-inositol significantly improved glycemic control, reduced insulin resistance, lowered triglycerides and VLDL-cholesterol levels, and upregulated PPAR-\u03b3 gene expression compared to metformin.", "population_specificity": "Women aged 18-40 with polycystic ovary syndrome (PCOS).", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:17.167790+00:00"}
{"study_id": 68261, "supplement_id": 1223, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the short-term efficacy and safety of Myo-inositol (MI) versus Metformin (MET) in treating PCOS patients, focusing on hormonal and metabolic outcomes.", "results_summary": "The study found no significant differences between MI and MET in improving fasting insulin, HOMA index, testosterone, SHBG levels, or BMI. MI showed better tolerability with fewer adverse events compared to MET.", "population_specificity": "Women with polycystic ovary syndrome (PCOS).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:17.812826+00:00"}
{"study_id": 68264, "supplement_id": 1223, "safety_score": "75", "efficacy_score": 45, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of oral inositol supplementation for reproductive outcomes in subfertile women with PCOS trying to conceive.", "results_summary": "The study found very low-quality evidence suggesting uncertain effects of myo-inositol on live birth rates, miscarriage rates, and clinical pregnancy rates in women with PCOS undergoing IVF pre-treatment. No conclusive differences were observed in multiple pregnancy rates compared to standard treatment.", "population_specificity": "Subfertile women with polycystic ovary syndrome (PCOS) undergoing IVF pre-treatment or ovulation induction.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:18.475685+00:00"}
{"study_id": 68265, "supplement_id": 1223, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to assess the efficacy and safety of Inositol (ISL) supplementation during pregnancy for preventing gestational diabetes (GDM).", "results_summary": "ISL supplementation was associated with a lower rate of GDM (OR 0.49) and preterm delivery (OR 0.35), with no adverse effects reported. The effect was significant only for the group receiving 2 g MYO twice daily.", "population_specificity": "Pregnant women without a prior diagnosis of GDM.", "effective_dosage": "MYO 2 g twice daily or MYO 1100 mg plus DCI 27.6 mg daily.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:19.200121+00:00"}
{"study_id": 68267, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the mechanisms underlying lamotrigine's mood-stabilizing effects in bipolar disorder, including potential roles of inositol phosphate pathways.", "results_summary": "The abstract does not provide specific findings on inositol but suggests that its role, along with other pathways like GSK3\u03b2, needs further investigation in the context of lamotrigine's mood-stabilizing effects.", "population_specificity": "Pre-clinical studies (animal models and in vitro research).", "effective_dosage": "Not specified for inositol.", "study_duration": "Not specified for inositol.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:19.339308+00:00"}
{"study_id": 68263, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to characterize a novel GNRHR mutation in a patient with normosmic congenital hypogonadotropic hypogonadism (ncHH) and evaluate the functional impact of this mutation using inositol phosphate signaling assays.", "results_summary": "The study identified a novel homozygous GNRHR mutation (p.Gly99Glu) in an ncHH patient, demonstrating severely decreased GnRH binding affinity. Functional assays confirmed a right-shifted GnRH-stimulated signaling response, indicating a severe partial loss-of-function mutation.", "population_specificity": "A male patient with normosmic congenital hypogonadotropic hypogonadism (ncHH) and his parents.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:19.642119+00:00"}
{"study_id": 68268, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of Myo-inositol in thyroid function and autoimmunity, particularly its effects on TSH levels and immune modulation in autoimmune thyroiditis.", "results_summary": "The study found that treatment with Myo-inositol plus seleniomethionine significantly reduced TSH levels and antithyroid autoantibodies in patients with subclinical hypothyroidism due to autoimmune thyroiditis, with a decline in serum CXCL10 levels indicating immune-modulatory effects.", "population_specificity": "Patients with subclinical hypothyroidism due to autoimmune thyroiditis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:22.231321+00:00"}
{"study_id": 68270, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine whether proton magnetic resonance spectroscopy could detect neurochemical changes in motor areas of the brain associated with functional decline in early-stage ALS.", "results_summary": "The study found that neurochemical changes in motor cortex areas were associated with functional decline in corresponding body regions in early-stage ALS patients.", "population_specificity": "Nineteen participants with early-stage ALS and 18 age- and sex-matched controls.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:24.684318+00:00"}
{"study_id": 68269, "supplement_id": 1223, "safety_score": "90", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to analyze the documented curative and healing properties of cyclitols, particularly in treating diabetes-related insulin resistance, obesity, and polycystic ovarian syndrome.", "results_summary": "Cyclitols demonstrated therapeutic potential in reducing metabolically induced inflammation and were noted for their good tolerance, low toxicity, and suitability for pregnant women and children. Their widespread availability also encourages medical use.", "population_specificity": "Pregnant women, children, and individuals with diabetes-related insulin resistance, obesity, or polycystic ovarian syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:25.395900+00:00"}
{"study_id": 68272, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of a nutraceutical combination (including myo-inositol) on semen parameters in sub-fertile men.", "results_summary": "The study found statistically significant improvements in sperm concentration, number of spermatozoa, progressive motility, total motile sperm count, and normal sperm morphology after 90 days of treatment.", "population_specificity": "Sub-fertile men aged 26-53, non-smokers, without testicular pathologies or metabolic/endocrine abnormalities.", "effective_dosage": "Not specified", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:26.731974+00:00"}
{"study_id": 68271, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether supplementing with myo-inositol provides additional benefits in improving ovulation and conception rates in women with PCOS undergoing a comprehensive lifestyle intervention or fertility medication.", "results_summary": "The abstract does not provide specific results regarding myo-inositol's effects, as it describes a planned study rather than completed findings. The trial is designed to evaluate ovulation rates, conception, and quality of life outcomes.", "population_specificity": "Women aged 18-37 diagnosed with PCOS (Rotterdam criteria) who are trying to conceive, excluding those already on fertility treatment, recent myo-inositol users, or individuals with eating disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:26.968568+00:00"}
{"study_id": 68273, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of myo-inositol in respiratory neural control and its potential benefits in clinical conditions like neonatal apnea and respiratory distress.", "results_summary": "The study found that myo-inositol plays a critical role in respiratory neural development, with deficiencies linked to neonatal apnea and respiratory insufficiency. Supplementation showed respiratory benefits in both animal models and preterm infants, reducing intermittent hypoxemia events.", "population_specificity": "Preterm infants and animal models (mice).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:27.491293+00:00"}
{"study_id": 68274, "supplement_id": 1223, "safety_score": "30", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to test the safety and efficacy of myo-inositol in reducing type 1 retinopathy of prematurity (ROP) and mortality in preterm infants younger than 28 weeks' gestational age.", "results_summary": "The study found that myo-inositol did not reduce the risk of type 1 ROP or death compared to placebo and was associated with a statistically significant increase in mortality (18% vs. 11%) and adverse events such as necrotizing enterocolitis, poor perfusion, and systemic infection.", "population_specificity": "Preterm infants younger than 28 weeks' gestational age.", "effective_dosage": "40 mg/kg every 12 hours (initially intravenously, then enterally when feeding).", "study_duration": "Up to 10 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:29.535011+00:00"}
{"study_id": 68275, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether myo-inositol plays a role in myelin formation through its facilitation of ethanolamine plasmalogen (PlsEtn) biosynthesis and its potential link between type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD).", "results_summary": "The study found that serum PlsEtn concentration associated with urinary myo-inositol (UMI) excretion was useful for predicting advancing dementia in patients with mild cognitive impairment (CI). Hyperglycemia and insulin resistance were suggested as leading causes of increased UMI excretion, implicating myo-inositol as a potential link between T2DM and AD.", "population_specificity": "Memory clinic outpatients (MCO) and cognitively normal elderly (NE) individuals.", "effective_dosage": "Not specified", "study_duration": "Nearly 4.5 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:30.417269+00:00"}
{"study_id": 68276, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were examining the role of PLC\u03b2 in intracellular signaling, particularly its generation of inositol triphosphate as a second messenger.", "results_summary": "The study found that PLC\u03b2, when activated by GPCRs, mediates phospholipid metabolism and produces inositol triphosphate and diacylglycerol, which are key second messengers in intracellular Ca signaling.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:31.134872+00:00"}
{"study_id": 68277, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of inositols (MI and DCI) in improving metabolic and hormonal states, restoring ovulation in PCOS, and their effectiveness in assisted reproductive technology.", "results_summary": "Inositols improved metabolic and hormonal states in PCOS, restored spontaneous ovulation, and enhanced ovarian stimulation parameters in assisted reproductive technology, though fertility outcome data were conflicting.", "population_specificity": "Women with polycystic ovary syndrome (PCOS), particularly those with hyperinsulinemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:32.491744+00:00"}
{"study_id": 68278, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of Inositol as a nutritional supplement in preventing gestational diabetes and its complications in pregnant women.", "results_summary": "The abstract does not provide specific results regarding Inositol's effects, as it describes the study protocol rather than outcomes.", "population_specificity": "Pregnant women at 12-15 weeks of gestation.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:32.839705+00:00"}
{"study_id": 68279, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effectiveness of myo-inositol (MI) supplementation combined with folic acid and liposomal magnesium in improving metabolic profile and HS symptoms in patients with impaired glucose metabolism.", "results_summary": "Group A (MI supplementation) showed significant reductions in Sartorius Score and HOMA-IR compared to Group B (control), suggesting MI improved HS symptoms and insulin resistance. The results were statistically significant, indicating clinical relevance.", "population_specificity": "20 subjects with Hidradenitis suppurativa (HS) and impaired glucose metabolism.", "effective_dosage": "MI 2000 mg daily, liposomal magnesium, and folic acid.", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:36.301276+00:00"}
{"study_id": 68281, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the effect of negative pressure wound therapy (NPWT) on gene expression in patients with type 2 diabetes and diabetic foot ulcers, including the role of genes like SYNJ1 (involved in inositol metabolism).", "results_summary": "The study identified four differentially expressed genes post-treatment, including SYNJ1 (synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1), suggesting NPWT may influence wound healing via molecular pathways involving inositol metabolism.", "population_specificity": "Patients with type 2 diabetes and diabetic foot ulcers (21 treated with NPWT, 8 with standard therapy).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:36.384457+00:00"}
{"study_id": 68282, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the physiological functions of nuclear phosphoinositides, including inositol-related signaling, and their potential clinical applications in diseases such as endometriosis, nonalcoholic fatty liver disease, glioblastoma, and hepatocellular carcinoma.", "results_summary": "The study identified nuclear proteins (SF-1, LRH-1) and enzymes (PTEN, IPMK) involved in solubilizing and remodeling nuclear phosphoinositides, linking these mechanisms to clinical pathologies and suggesting opportunities for new biomarkers and therapeutics.", "population_specificity": "Not specified (basic science focus on molecular mechanisms).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:37.628544+00:00"}
{"study_id": 68286, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of myo-inositol versus placebo on hypoglycemia in women with gestational diabetes mellitus (GDM).", "results_summary": "The study found no conclusions could be drawn regarding myo-inositol's effects on hypoglycemia due to insufficient evidence. The evidence quality was noted as low or very low.", "population_specificity": "Pregnant women with gestational diabetes mellitus (GDM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:38.622638+00:00"}
{"study_id": 68283, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to assess the reliability of extending TFPI-related studies in mice to humans by comparing mouse and human TFPI physiology.", "results_summary": "The study found that while mouse and human TFPI share similarities in mechanisms of inhibition and isoform characteristics, they differ significantly in circulating concentrations and the presence of TFPI\u03b3 in mice, which is absent in humans. TFPI\u03b3 null mice may better reflect human TFPI physiology for future studies.", "population_specificity": "Mouse models and human TFPI physiology.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:38.723091+00:00"}
{"study_id": 68285, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to analyze the role of endoplasmic reticulum stress factors, including inositol-requiring enzyme 1 isoform \u03b1 (IRE1\u03b1), in pancreatic ductal adenocarcinoma (PDAC) and their potential to induce tumor dormancy as a chemotherapeutic target.", "results_summary": "The study compiled evidence suggesting that endoplasmic reticulum stress factors like IRE1\u03b1 may modulate tumor dormancy in PDAC, potentially prolonging patient survival, but did not specifically evaluate inositol's direct effects.", "population_specificity": "Pancreatic ductal adenocarcinoma (PDAC) patients and related preclinical research.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:40.118059+00:00"}
{"study_id": 68288, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "To determine if oral myo-inositol supplementation reduces gonadotropin use and shortens controlled ovarian hyperstimulation duration in PCOS and non-PCOS women undergoing IVF.", "results_summary": "Myo-inositol reduced gonadotropin use in both PCOS and non-PCOS women and shortened hyperstimulation duration only in PCOS women. The effects were statistically significant.", "population_specificity": "PCOS and non-PCOS women undergoing IVF.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:40.237456+00:00"}
{"study_id": 68287, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate how genetic manipulation of Ca2+ signaling pathways, including inositol-1,4,5-trisphosphate (InsP3)-dependent mechanisms, could enhance the therapeutic potential of endothelial colony forming cells (ECFCs) for angiogenesis.", "results_summary": "The study found that InsP3-dependent Ca2+ release, along with other Ca2+ signaling pathways, plays a critical role in ECFC proliferation, migration, and neovessel formation, suggesting potential for therapeutic angiogenesis. VEGF and SDF-1\u03b1 were shown to trigger Ca2+ oscillations in ECFCs, mediated by InsP3 receptors and store-operated Ca2+ entry.", "population_specificity": "Endothelial colony forming cells (ECFCs) derived from peripheral blood and umbilical cord blood.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:42.551750+00:00"}
{"study_id": 68290, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to summarize existing evidence on treatments for PCOS, including inositol, to address infertility and improve pregnancy outcomes.", "results_summary": "The abstract suggests inositol is considered among treatment strategies for PCOS, but specific efficacy results are not detailed. It highlights insulin-sensitizing agents, including inositol, as important for managing insulin resistance.", "population_specificity": "Women with polycystic ovary syndrome (PCOS) seeking pregnancy.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:44.253262+00:00"}
{"study_id": 68289, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of inositol, among other drugs, in inducing weight loss in women with PCOS and overweight/obesity.", "results_summary": "The study found that inositol was less effective than liraglutide, orlistat, and metformin in inducing weight loss, with no significant effects on waist circumference or waist-to-hip ratio reported.", "population_specificity": "Women with polycystic ovary syndrome (PCOS) and overweight/obesity.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:44.295543+00:00"}
{"study_id": 68293, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not specify a study goal related to Inositol.", "results_summary": "The abstract does not report any findings related to Inositol.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:46.259862+00:00"}
{"study_id": 68291, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers were attempting to determine the mechanisms by which Bcl-2 inhibits cell death, specifically focusing on the role of its BH4 domain in binding to the inositol 1,4,5-trisphosphate receptor (IP3R).", "results_summary": "The study found that Bcl-2 inhibits cell death through two mechanisms: binding pro-apoptotic proteins via its BH3 domain and interacting with the IP3R via its BH4 domain. The abstract does not provide specific results regarding Inositol's effects.", "population_specificity": "Not specified (likely in vitro or animal model based on context).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:47.225059+00:00"}
{"study_id": 68292, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers reviewed the current state of complement therapeutics, focusing on C3-targeted and alternative pathway-directed drug candidates for treating PNH, including the role of glycosyl phosphatidyl inositol-linked regulators.", "results_summary": "The abstract discusses the pathology of PNH driven by complement dysregulation due to the lack of glycosyl phosphatidyl inositol-linked regulators (DAF and CD59), leading to chronic hemolysis, and highlights emerging therapies targeting complement pathways.", "population_specificity": "Patients with paroxysmal nocturnal hemoglobinuria (PNH).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:47.297070+00:00"}
{"study_id": 68294, "supplement_id": 1223, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to synthesize the effects of inositol on glucose homeostasis in various clinical conditions through a meta-analysis of randomized controlled trials.", "results_summary": "Inositol supplementation significantly reduced fasting plasma glucose, 2-hour post-OGTT glucose, fasting insulin, and HOMA-IR, indicating improved insulin sensitivity without affecting BMI or HbA1c. Adverse events were mentioned in 13 articles but were not serious.", "population_specificity": "1,239 subjects across 20 randomized controlled trials.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:49.787928+00:00"}
{"study_id": 68296, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to determine if myo-inositol hexaphosphate (IP6) could reduce metal-catalyzed protein glycation, a potential trigger for diabetes-related diseases.", "results_summary": "In vitro studies showed that IP6 reduced the formation of Fe-related glycation, suggesting potential efficacy in mitigating diabetes-related complications.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:49.807523+00:00"}
{"study_id": 68295, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers examined the role of glycosyl-phosphatidyl-inositol (GPI)-specific auto-immune attack in the expansion of PIGA mutant clones in aplastic anaemia and paroxysmal nocturnal haemoglobinuria (PNH).", "results_summary": "The study found that PIGA mutant clones expand due to Darwinian selection from a GPI-specific auto-immune attack, enabling haematopoietic recovery in PNH patients, while similar but less effective mechanisms may occur with HLA mutations. Other mutant clones in aplastic anaemia, though not causative, may be pre-leukaemic and generally fail to restore haematopoiesis.", "population_specificity": "Patients with aplastic anaemia (AA) and paroxysmal nocturnal haemoglobinuria (PNH).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:50.867010+00:00"}
{"study_id": 68298, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of inositol-related phosphatases (SHIP) in cancer treatment and the challenges in developing inhibitors for these targets.", "results_summary": "The study highlights SHIP as a negative regulator of immune response by hydrolyzing PIP3, with deficiency linked to myeloproliferation and B-cell lymphoma in mice. It discusses the difficulties in targeting SHP-1, SHP-2, and SHIP due to their conserved active sites, but notes progress in developing novel inhibitors.", "population_specificity": "Preclinical (mice) and theoretical human applications in oncology.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:53.064842+00:00"}
{"study_id": 68299, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the role of Inositol in addressing airway remodeling, specifically hyperplasia of airway smooth muscle cells (ASMCs), in asthma.", "results_summary": "The abstract does not provide specific findings regarding Inositol's effects.", "population_specificity": "Asthma patients with airway remodeling (ASMC hyperplasia).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:53.256627+00:00"}
{"study_id": 68300, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify serum metabolites, including chiro-inositol, associated with adherence to the DASH dietary pattern compared to other diets.", "results_summary": "Chiro-inositol was among the 10 most influential metabolites for discriminating between the DASH and control dietary patterns, indicating its potential role as a biomarker for dietary adherence. The study did not assess direct health effects of inositol.", "population_specificity": "329 participants in a multicenter, randomized clinical feeding study (DASH diet n=110, fruit and vegetables diet n=111, control diet n=108).", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:56.248465+00:00"}
{"study_id": 68301, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to uncover the endoplasmic reticulum (ER) stress pathway involved in curcumin-induced apoptosis in thyroid cancer cells, not specifically focused on inositol.", "results_summary": "The study found that curcumin induced ER stress and unfolded protein response (UPR) in thyroid cancer cells, leading to apoptosis, but did not specifically report on inositol's effects.", "population_specificity": "Human papillary thyroid carcinoma BCPAP cells.", "effective_dosage": "Not specified for inositol.", "study_duration": "Not specified for inositol.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:56.737944+00:00"}
{"study_id": 68303, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers reviewed the scientific and patent literature on various sulfonamide inhibitors, including phosphatidyl inositol 3-kinase, to evaluate their potential therapeutic applications.", "results_summary": "The abstract does not provide specific findings on Inositol's effects, focusing instead on broader sulfonamide applications in various conditions like cancer, glaucoma, and inflammation.", "population_specificity": "Not specified (review of literature, not a clinical study)", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:57.959782+00:00"}
{"study_id": 68302, "supplement_id": 1223, "safety_score": "90", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the role of Inositol as a treatment option for anovulatory women with PCOS, focusing on its safety and efficacy in improving ovulation.", "results_summary": "The study found that Inositol has a documented effect on ovulation and no adverse effects at recommended doses, making it a viable first-line treatment option for PCOS. It was suggested alongside other treatments like insulin sensitizers and aromatase inhibitors, which showed higher ovulation and live birth rates.", "population_specificity": "Anovulatory women with polycystic ovary syndrome (PCOS), particularly obese/overweight individuals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:58.512572+00:00"}
{"study_id": 68304, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the role of lipid messengers produced by PI3Ks, including inositol derivatives, in normal cells, cancer cells, and platelets during arterial thrombosis.", "results_summary": "The abstract does not provide specific findings about Inositol's effects, only mentioning its involvement in PI3K-mediated lipid phosphorylation.", "population_specificity": "Not specified (abstract mentions normal cells, cancer cells, and platelets).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:08:58.803710+00:00"}
{"study_id": 68305, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not mention Inositol or its effects, focusing instead on presenilin proteins and their role in Alzheimer's disease.", "results_summary": "The abstract does not discuss Inositol or its effects.", "population_specificity": "Not specified (abstract focuses on familial Alzheimer's disease mechanisms).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:00.126294+00:00"}
{"study_id": 68306, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review disrupted signaling pathways in hepatocellular carcinoma (HCC), including the phosphatidyl inositol 3-kinase/Akt/mechanistic target of rapamycin pathway, and discuss targeted therapy and immunotherapy trials for HCC.", "results_summary": "The abstract highlights disrupted signaling pathways in HCC, including the phosphatidyl inositol 3-kinase/Akt/mTOR pathway, and mentions ongoing investigations into agents targeting these pathways. It also notes the development of immunotherapy for HCC patients.", "population_specificity": "Patients with hepatocellular carcinoma (HCC).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:01.688978+00:00"}
{"study_id": 68297, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of IRE1\u03b1 in the pathophysiology of autoimmune diseases and its potential as a therapeutic target.", "results_summary": "The abstract discusses the involvement of IRE1\u03b1 in ER stress and immune responses but does not provide specific findings on Inositol's effects. It highlights the need for further research to elucidate IRE1\u03b1's role in autoimmunity.", "population_specificity": "Not specified (focus on molecular mechanisms in autoimmune diseases).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:02.365834+00:00"}
{"study_id": 68309, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not mention Inositol or its study.", "results_summary": "The abstract does not discuss Inositol or its effects.", "population_specificity": "Not specified (abstract focuses on spinocerebellar ataxia).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:04.242671+00:00"}
{"study_id": 68307, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of inositol-requiring enzyme 1\u03b1 (IRE1) in tumor cells' adaptive pathways and its impact on the tumor microenvironment and immune response.", "results_summary": "The study found that tumoral UPR, mediated by IRE1, controls the tumor microenvironment and immune response, suggesting potential new therapeutic approaches for cancer.", "population_specificity": "Tumor cells and their microenvironment (not human subjects).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:04.277832+00:00"}
{"study_id": 68308, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the role of ATF6, including its interaction with inositol requiring enzyme 1 (IRE1), in organogenesis and tissue homeostasis.", "results_summary": "The abstract highlights ATF6's role in ER stress response and its regulatory functions in development and tissue maintenance, but does not specifically report on inositol's effects.", "population_specificity": "Not specified (review of human, rodent, fish, goat, and bovine research).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:04.576088+00:00"}
{"study_id": 68311, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine if inositol phosphate metabolism is dysregulated in community-acquired pneumonia (CAP) patients and whether this could serve as a biomarker for disease severity.", "results_summary": "Inositol phosphate was identified as one of the significantly dysregulated metabolites in CAP patients, suggesting its involvement in metabolic changes related to disease severity, though specific efficacy for inositol supplementation was not directly assessed.", "population_specificity": "175 individuals (119 CAP patients and 56 controls), divided into discovery and validation cohorts.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:07.741322+00:00"}
{"study_id": 68310, "supplement_id": 1223, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of different dosages of inositol stereoisomers on insulin resistance levels and maternal-fetal outcomes in women with gestational diabetes mellitus (GDM).", "results_summary": "The study found that myo-inositol (MI) supplementation significantly reduced insulin resistance (HOMA-IR) and weight gain in GDM women, while also decreasing the need for intensified insulin treatment. Newborns of women treated with inositol had lower birth weights compared to the control group.", "population_specificity": "Women diagnosed with gestational diabetes mellitus (GDM).", "effective_dosage": "4000 mg myo-inositol, 500 mg D-chiro-inositol, or 1100/27.6 mg myo/D-chiro-inositol plus 400 mcg folic acid daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:08.286950+00:00"}
{"study_id": 68313, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the physiological and pathophysiological roles of IRE1 signaling, a branch of the unfolded protein response, in central nervous system diseases.", "results_summary": "The study highlights that IRE1 signaling dysfunction is implicated in various neurological disorders and suggests targeting this pathway as a potential therapeutic strategy. It provides an overview of IRE1's expression, function, and pathological roles in CNS diseases.", "population_specificity": "Not specified (review of existing literature on IRE1 signaling in neurological disorders).", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:10.142644+00:00"}
{"study_id": 68312, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of myo-inositol (MI) plus selenium (Se) on thyroid nodule size, elasticity, and TSH levels in patients with subclinical hypothyroidism (SCH) or borderline TSH levels.", "results_summary": "The study found that MI plus Se supplementation significantly reduced thyroid nodule size in 76% of cases, improved elasticity in 56%, and decreased TSH levels from 4.2 to 2.1 mIU/L. The control group showed less reduction in nodule size (38%) and an increase in TSH levels.", "population_specificity": "Patients with subclinical hypothyroidism or borderline TSH levels and thyroid nodules classified as class I and II.", "effective_dosage": "1 tablet containing MI plus Se daily", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:10.397107+00:00"}
{"study_id": 68314, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of inositol-requiring enzyme 1\u03b1 (a component of the UPR pathway) in diabetic cardiomyopathies by comparing its expression in epicardial adipose tissue (EAT) versus subcutaneous adipose tissue (SAT).", "results_summary": "The study found upregulation of UPR markers, including inositol-requiring enzyme 1\u03b1, in EAT compared to SAT, suggesting its involvement in diabetic cardiomyopathies. However, no direct effects of inositol supplementation were assessed.", "population_specificity": "Diabetic patients with cardiovascular disease risk.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:10.986270+00:00"}
{"study_id": 68315, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to elucidate the pathophysiology of lithium-induced nephrotoxicity, including the role of inositol signalling pathways.", "results_summary": "The abstract suggests that alterations in inositol signalling pathways are involved in lithium-induced nephrotoxicity and nephrogenic diabetes insipidus, but it does not provide specific findings on inositol's effects.", "population_specificity": "Patients with bipolar disorder experiencing lithium-induced nephrotoxicity.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:11.660597+00:00"}
{"study_id": 68317, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the mechanisms of new chemotherapeutic agents, including phosphatidyl inositol 3-kinase inhibitors, for treating breast cancer brain metastases (BCBM).", "results_summary": "The abstract provides a historical overview of BCBM chemotherapy and reviews the mechanisms of various new agents, including phosphatidyl inositol 3-kinase inhibitors, but does not report specific results regarding inositol's effects.", "population_specificity": "Women with breast cancer brain metastases (BCBM).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:12.500689+00:00"}
{"study_id": 68316, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review signaling pathways in multiple myeloma (MM) cells, focusing on drug resistance mechanisms involving phosphatidyl inositol 3-kinase/AKT and other pathways.", "results_summary": "The study concluded that drug resistance in MM is influenced by the bone marrow microenvironment and signaling pathways, suggesting combination therapies with uncommon compounds could improve treatment efficacy. Inositol-related pathways were implicated in cell survival and drug resistance, but direct effects of inositol supplementation were not evaluated.", "population_specificity": "Patients with multiple myeloma (MM), typically aged >50 years.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:12.860065+00:00"}
{"study_id": 68318, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to identify chromosomal loci influencing the risk of coronary artery disease (CAD) and its risk factors, focusing on the GUCY1A3 gene.", "results_summary": "The abstract does not provide specific findings related to Inositol.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:14.242201+00:00"}
{"study_id": 68321, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and tolerability of a gender-matched oral supplement containing myo-inositol (for females) in treating mild to moderate acne.", "results_summary": "The study found that patients taking the oral supplement showed statistically significant improvement in acne severity (measured by GAGs) by week 12, with females receiving myo-inositol experiencing satisfactory therapeutic responses.", "population_specificity": "Male and female patients with mild to moderate acne.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:17.745071+00:00"}
{"study_id": 68320, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of the unfolded protein response (UPR), including inositol-requiring protein 1 (IRE1), in the pathophysiology of ischemic heart disease and its therapeutic potential.", "results_summary": "The study found that the UPR, including IRE1, plays a critical role in cardiac response to ischemia, with distinct but overlapping effects in managing protein-folding stress and determining cell survival or death. The UPR's activation can either restore cellular homeostasis or trigger apoptosis, depending on the severity and persistence of stress.", "population_specificity": "Not specified (general focus on ischemic heart disease pathophysiology).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:18.702139+00:00"}
{"study_id": 68324, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to analyze the longitudinal presence of inositol phosphoglycan (IPG) in urine to predict the onset of pre-eclampsia (PE) and compare it with clinical diagnosis timing.", "results_summary": "The study identified two subgroups (early and late-onset PE) based on IPG biomarker presence, predicting clinical onset 2-4 weeks prior to diagnosis, suggesting similar etiology for both groups.", "population_specificity": "Pregnant women giving birth in Mauritius (n=920, with 77 developing PE).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:20.547979+00:00"}
{"study_id": 68323, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of inositols (Myo-inositol, D-chiro-inositol, and their combination) in managing PCOS and preventing/treating gestational diabetes mellitus (GDM).", "results_summary": "The study found that Myo-inositol, D-chiro-inositol, and their combination in a 40:1 ratio improved metabolic, hormonal, and reproductive aspects of PCOS. Myo-inositol monotherapy was more effective in preventing and treating GDM, though further studies are needed for confirmation.", "population_specificity": "Women with polycystic ovary syndrome (PCOS) and those at risk for or with gestational diabetes mellitus (GDM).", "effective_dosage": "Physiological ratio of 40:1 (Myo-inositol to D-chiro-inositol)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:20.982202+00:00"}
{"study_id": 68326, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the efficacy of myoinositol supplementation in improving clinical pregnancy rates and other reproductive outcomes in infertile women undergoing ovulation induction for ICSI or IVF-ET.", "results_summary": "Myoinositol supplementation significantly improved clinical pregnancy rates, reduced abortion rates, enhanced embryo quality, decreased unsuitable oocytes, and lowered the required amount of ovulation drugs. No significant differences were observed in total oocytes retrieved, MII stage oocytes, stimulation days, or E2 peak levels.", "population_specificity": "Infertile women undergoing ovulation induction for ICSI or IVF-ET.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:21.093054+00:00"}
{"study_id": 68319, "supplement_id": 1223, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and efficacy of myo-inositol and folic acid in improving symptoms, infertility, and oocyte quality in women with PCOS, including those undergoing IVF.", "results_summary": "The study found that myo-inositol and folic acid restored ovulation in 70% of women, resulted in a 15.1% pregnancy rate, improved hormonal levels, and enhanced oocyte quality and fertilization rates in IVF patients. No relevant side effects were reported.", "population_specificity": "Infertile women with polycystic ovary syndrome (PCOS), including a subgroup undergoing IVF treatment.", "effective_dosage": "2 \u00d7 2000 mg myo-inositol + 2 \u00d7 200 \u03bcg folic acid per day (general group); 4000 mg myo-inositol + 400 \u03bcg folic acid per day (IVF subgroup).", "study_duration": "2-3 months (general group); 2 months (IVF subgroup).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:21.928351+00:00"}
{"study_id": 68327, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether different myo-inositol and D-chiro-inositol concentrations in follicular fluid correlate with blastocyst quality in healthy young women undergoing IVF.", "results_summary": "The study found that a higher myo-inositol/D-chiro-inositol ratio in follicular fluid was significantly associated with good-quality blastocysts, lower D-chiro-inositol content correlated with better implantation and pregnancy rates, and pre-treatment with myo-inositol may improve IVF outcomes.", "population_specificity": "Healthy young women (egg donors and couples undergoing IVF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:22.150905+00:00"}
{"study_id": 68322, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the neuroprotective effects of lithium (via its action on inositol monophosphatase-1) in neurodegenerative disorders by reviewing clinical studies.", "results_summary": "Lithium showed potential neuroprotective effects in psychiatric populations with lower Alzheimer's prevalence, improved symptoms in mild cognitive impairment and Huntington's disease, but lacked consistent benefits in amyotrophic lateral sclerosis. Benefits in spinocerebellar ataxia were noted for cerebellar symptoms.", "population_specificity": "Patients with Alzheimer's disease, mild cognitive impairment, Huntington's disease, amyotrophic lateral sclerosis, and spinocerebellar ataxia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:22.784287+00:00"}
{"study_id": 68328, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 60, "study_goal": "The researchers aimed to assess the analgesic efficacy of acupuncture compared to other therapies, including inositol, for chronic neuropathic pain in adults.", "results_summary": "Acupuncture may reduce the risk of 'no clinical response' to pain compared to other therapies like inositol, but evidence for pain intensity, relief, or adverse events was not available. The overall quality of evidence was very low due to study limitations and small sample sizes.", "population_specificity": "Adults with chronic peripheral neuropathic pain (mean ages 52 to 63 years, predominantly from China and the UK).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:26.147434+00:00"}
{"study_id": 68329, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of insulin-sensitising drugs, including D-chiro-inositol, in improving reproductive and metabolic outcomes for women with PCOS undergoing ovulation induction.", "results_summary": "The study included D-chiro-inositol among the assessed interventions but did not provide specific efficacy or safety results for it, focusing more on metformin and clomiphene citrate. The overall evidence quality ranged from very low to moderate, with limitations such as risk of bias and inconsistency.", "population_specificity": "Women with oligo and anovulatory PCOS.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:27.145353+00:00"}
{"study_id": 68332, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether myo-inositol reduces the growth of abdominal aortic aneurysms (AAAs) in patients.", "results_summary": "The study is ongoing, so no results regarding Inositol's effects on AAA growth are reported in the abstract.", "population_specificity": "164 participants with an AAA measuring \u226530 mm.", "effective_dosage": "2 g of myo-inositol twice daily.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:28.658601+00:00"}
{"study_id": 68331, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of HRF/TCTP in allergic and inflammatory responses, including its potential as a therapeutic target in asthma and allergy.", "results_summary": "The study highlights HRF/TCTP's activation of immune cells (basophils, eosinophils, T cells, B cells) and its potential to exacerbate allergic inflammation, while also discussing SHIP-1 agonists as possible modulators of inflammatory disorders.", "population_specificity": "Not specified (focus on molecular and cellular mechanisms).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:28.660059+00:00"}
{"study_id": 68333, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers discussed the potential of phosphatidyl-inositol-3-kinase inhibitors as a promising treatment option for adult lymphoma patients, but did not specifically study Inositol's effects.", "results_summary": "The abstract mentions phosphatidyl-inositol-3-kinase inhibitors as a promising new treatment option in adult lymphoma, but no specific results regarding Inositol's effects are provided.", "population_specificity": "Adult and pediatric lymphoma patients (no specific focus on Inositol).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:28.722917+00:00"}
{"study_id": 68335, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to summarize current treatments for PCOS, including inositol, as a potential therapy for refractory ovulation disorders.", "results_summary": "Inositol was listed among the latest treatments for refractory ovulation disorders in PCOS, suggesting it may be effective for fertility-related issues, but no specific efficacy data or outcomes were detailed.", "population_specificity": "Women with polycystic ovary syndrome (PCOS) and refractory ovulation disorders.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:29.733080+00:00"}
{"study_id": 68337, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to systematically review current scientific evidence on the potential benefits of inositol isomers for diabetes and gestational diabetes.", "results_summary": "The review found that inositol may improve fasting blood glucose and other biochemical parameters in diabetic individuals, but larger and longer-term studies are needed to confirm its effectiveness as a diabetes management strategy.", "population_specificity": "Diabetic and gestational diabetic individuals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:30.124975+00:00"}
{"study_id": 68334, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the potential role of inositol pyrophosphates in addressing insulin resistance by influencing the PI3K-Akt/PKB pathway.", "results_summary": "The abstract suggests that inositol pyrophosphates may play a role in mitigating insulin resistance by affecting the PI3K-Akt/PKB pathway, which is crucial for glucose uptake, but does not provide specific experimental results or outcomes.", "population_specificity": "Not specified (abstract focuses on mechanistic insights rather than a specific study population).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:30.632463+00:00"}
{"study_id": 68338, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy of inositol as an adjunctive treatment to antidepressants in individuals with clinically diagnosed major depressive disorder (MDD).", "results_summary": "The preliminary data on inositol was negative, indicating no significant efficacy as an adjunctive treatment for MDD. The study noted insufficient or inconclusive data for most substances, including inositol.", "population_specificity": "Individuals with clinically diagnosed major depressive disorder (MDD).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:34.743176+00:00"}
{"study_id": 68339, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to highlight the nutritional and therapeutic benefits of kiwiberry, particularly its rich content of myo-inositol and other bioactive compounds.", "results_summary": "The study found that kiwiberry is one of the richest dietary sources of myo-inositol (up to 982 mg/100 g FW) and has potential antioxidant, anti-tumor, and anti-inflammatory properties, with early research suggesting benefits for gastrointestinal health, hypercholesterolemia, and certain cancers.", "population_specificity": "Not specified (general dietary context)", "effective_dosage": "Not specified (dietary intake levels inferred)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:34.841810+00:00"}
{"study_id": 68340, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare the effects of myo-inositol and metformin on mental health parameters and oxidative stress biomarkers in women with PCOS.", "results_summary": "Myo-inositol significantly improved mental health scores (depression, anxiety, stress) and increased plasma total antioxidant capacity compared to metformin, but did not affect glutathione or malondialdehyde levels.", "population_specificity": "60 women diagnosed with PCOS according to the Rotterdam criteria.", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:36.951063+00:00"}
{"study_id": 68342, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the role of endoplasmic reticulum stress and dysregulated signaling in pancreatic \u03b2 cell failure in monogenic and polygenic forms of diabetes.", "results_summary": "The study found substantial evidence for endoplasmic reticulum stress in \u03b2 cells in type 1 and type 2 diabetes, with insights from monogenic forms of diabetes and rodent models, suggesting therapeutic modulation of this stress response could be beneficial.", "population_specificity": "Pancreatic \u03b2 cells in monogenic and polygenic forms of diabetes (type 1 and type 2).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:37.253909+00:00"}
{"study_id": 68343, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore strategies for preserving pancreatic \u03b2-cell function in type 2 diabetes mellitus (T2DM) by reducing systemic metabolic burden rather than increasing insulin demand.", "results_summary": "The study highlights the plasticity of \u03b2-cells in insulin production and secretion, advocating for treatment approaches that reduce metabolic stress to preserve \u03b2-cell function and delay T2DM progression.", "population_specificity": "Not specified (general focus on T2DM and pancreatic \u03b2-cell function)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:38.250711+00:00"}
{"study_id": 68344, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the potential of novel antifungal agents, including inositol acyltransferase AX001, as alternatives to current treatments for invasive fungal infections.", "results_summary": "The abstract mentions AX001 as an investigational agent with a novel mechanism of action, but no specific results regarding its efficacy or safety are provided.", "population_specificity": "Not specified (abstract discusses general potential for treating invasive mycoses).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:38.315703+00:00"}
{"study_id": 68347, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the role of inositol-requiring enzyme 1 (IRE1) in the unfolded protein response (UPR) and its implications for diseases like neurodegenerative disorders, diabetes, and cancer.", "results_summary": "The study describes the activation of IRE1 during ER stress and its role in the UPR, which helps mitigate defective protein accumulation, but does not directly assess inositol's effects.", "population_specificity": "Not specified (cellular/molecular focus)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:42.160453+00:00"}
{"study_id": 68346, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate inositol's role in improving insulin resistance and its potential anti-cancer properties by modulating key biochemical pathways.", "results_summary": "The study found that inositol acts as an insulin sensitizer, counteracting hyperinsulinemia and hyperglycemia, and may interfere with glucose metabolism and carcinogenesis by modulating critical pathways like PI3K/Akt, PDH, and AMPK. Preliminary in vivo studies also showed beneficial effects on glucose homeostasis and cancer growth inhibition.", "population_specificity": "Not specified (general focus on conditions associated with insulin resistance and cancer).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:43.293121+00:00"}
{"study_id": 68349, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to assess whether dietary myo-inositol reduces stem cell activation in colitis and validate the role of p\u03b2-catenin.", "results_summary": "The study found that dietary myo-inositol affected inflammation and p\u03b2-catenin levels in mice, with increased p\u03b2-catenin observed in crypts.", "population_specificity": "Mice with colitis.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:43.815728+00:00"}
{"study_id": 68348, "supplement_id": 1223, "safety_score": "85", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy and safety of inositol as a natural treatment for PCOS, particularly in reducing insulin resistance and improving ovulatory performance.", "results_summary": "The study found that inositol has good efficacy, similar to metformin but with fewer side effects, and it helps reduce insulin resistance and improve ovulatory function in PCOS patients.", "population_specificity": "Women of reproductive age with polycystic ovary syndrome (PCOS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:43.998697+00:00"}
{"study_id": 68341, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of inositol-requiring enzyme 1\u03b1 in ER stress and its implications for kidney diseases, including podocyte injury and albuminuria.", "results_summary": "The study found that disruption of the UPR, involving inositol-requiring enzyme 1\u03b1, leads to podocyte injury and albuminuria in aging mice. Chemical chaperones, including those improving protein folding, alleviated kidney injury in experimental models.", "population_specificity": "Aging mice with podocyte injury and albuminuria.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:44.826027+00:00"}
{"study_id": 68351, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 35, "quality_score": 75, "study_goal": "The researchers aimed to assess the effectiveness of myo-inositol (MYO) and d-chiro-inositol (DCI) in improving oocyte/embryo quality and pregnancy rates for women with PCOS undergoing ICSI.", "results_summary": "MYO supplementation did not significantly improve oocyte quality, embryo quality, or pregnancy rates in women with PCOS. The study highlights the need for further research on DCI dosage and duration.", "population_specificity": "Women with PCOS undergoing intracytoplasmic sperm injection (ICSI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:46.576363+00:00"}
{"study_id": 68345, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the effects of lithium on biological processes, including its role in inositol depletion and mitochondrial function.", "results_summary": "Lithium improves mitochondrial function via inositol depletion, influencing energy production and oxidative stress. It also impacts neuroprotection and cognitive deficits through its effects on phospholipid metabolism.", "population_specificity": "Not specified (review of existing studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:49.280529+00:00"}
{"study_id": 68352, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether oral antioxidants, including myo-inositol and D-chiro-inositol, improve fertility outcomes for subfertile women compared to placebo, no treatment, or other antioxidants.", "results_summary": "The study found very low-quality evidence suggesting that antioxidants, including inositol, may be associated with increased live birth rates, but the evidence was insufficient to draw definitive conclusions about efficacy or adverse events.", "population_specificity": "Subfertile women attending reproductive clinics.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:50.037343+00:00"}
{"study_id": 68353, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of mGluR5 receptors, linked to the inositol trisphosphate pathway, in central and peripheral organ pathologies, including gastrointestinal and liver conditions.", "results_summary": "The study found that mGluR5 blockade reduces reflux episodes and transient lower sphincter relaxation, mitigates intestinal inflammation and visceral pain, and protects against ischemic liver injury in experimental models.", "population_specificity": "Animal models (rats and mice) and human studies (gastroesophageal pathways).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:54.100058+00:00"}
{"study_id": 68355, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of myo-inositol (MI) combined with selenium (Se) in restoring normal thyroid function and improving quality of life in patients with Hashimoto's thyroiditis and subclinical hypothyroidism.", "results_summary": "The study found that combined MI-Se treatment significantly reduced TSH, TPOAb, and TgAb levels, increased free serum T4, and improved patients' quality of life after six months compared to Se alone. The results suggest MI-Se is effective in restoring euthyroidism in autoimmune thyroiditis patients.", "population_specificity": "168 patients with Hashimoto's thyroiditis and subclinical hypothyroidism (TSH levels between 3 and 6 \u00b5IU/ml).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:54.856543+00:00"}
{"study_id": 68354, "supplement_id": 1223, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of topical InsP6 in improving quality of life and reducing chemotherapy-induced side effects in women with breast cancer.", "results_summary": "Patients using topical InsP6 showed significant improvements in quality of life, functional status, and reduced side effects compared to the control group. Additionally, significant differences in white blood cell and platelet counts were observed between the two groups after treatment.", "population_specificity": "Women with ductal breast cancer undergoing chemotherapy post-lumpectomy.", "effective_dosage": "4% topical formulation applied once daily.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:54.960715+00:00"}
{"study_id": 68357, "supplement_id": 1223, "safety_score": "90", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to determine the effect of myo-inositol combined with minerals and vitamins on sperm motility in men with asthenozoospermia.", "results_summary": "The study found a significant improvement in sperm motility in 85.32% of patients, with 34.86% restoring normal motility. A small percentage (1.84%) showed worsened motility, but no side effects were reported.", "population_specificity": "109 Bulgarian men aged 18-50 with reduced sperm motility (asthenozoospermia).", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:55.771003+00:00"}
{"study_id": 68350, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of inositol, among other nutrients, on cognitive function and functional abilities in individuals with Alzheimer's disease.", "results_summary": "The study found no significant effect of inositol supplementation on cognitive function or other outcome measures in Alzheimer's disease patients. The results were consistent with other nutrients tested, showing no clinically meaningful benefits when delivered individually.", "population_specificity": "Individuals with Alzheimer's disease", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:56.180640+00:00"}
{"study_id": 68356, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether oral pretreatment with a myo-inositol-based supplement and direct sperm incubation with myo-inositol could improve PICSI outcomes in infertile men with oligoasthenoteratozoospermia and previous failed PICSI procedures.", "results_summary": "The treatment group showed a significantly higher fertilization index and rate of good quality embryos, along with 11 pregnancies, while no pregnancies occurred in the control group. No significant differences were found in mature oocyte rates or the number of transferred embryos between groups.", "population_specificity": "Infertile men with oligoasthenoteratozoospermia and previous failed PICSI procedures.", "effective_dosage": "Oral supplement (Folandrol\u00ae) for two months; sperm incubated with 2 mg/ml myo-inositol for 2 hours.", "study_duration": "Two months of oral supplementation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:57.525863+00:00"}
{"study_id": 68359, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the correlation between male infertility, reactive oxygen species levels, and the potential therapeutic use of inositol.", "results_summary": "The study highlighted inositol's role in addressing male infertility by potentially mitigating reactive oxygen species-related sperm dysfunction, though specific efficacy data were not detailed in the abstract.", "population_specificity": "Males with oligoasthenoteratospermia (defective spermatogenesis characterized by reduced sperm motility, count, and altered morphology).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:58.468294+00:00"}
{"study_id": 68358, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to analyze the bioavailability of inositol stereoisomers (myo-inositol and D-chiro-inositol) to determine the optimal dosing regimen for clinical use.", "results_summary": "The study found that splitting a 4 g dose of myo-inositol into two 2 g administrations provided better 24-hour coverage compared to a single 4 g dose, with no significant pharmacokinetic advantage for the single dose. The differences in bioavailability were linked to maximum concentration (Cmax) but not time.", "population_specificity": "Not specified (general clinical context implied, possibly PCOS and infertility patients).", "effective_dosage": "4 g total daily dose (either as a single 4 g dose or 2 g twice daily).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:09:59.558808+00:00"}
{"study_id": 68360, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine whether myo-inositol (MYO) supplementation improves sensitivity to clomiphene citrate (CC) in terms of ovulation and pregnancy rates in PCOS patients.", "results_summary": "MYO+CC showed a significantly higher ovulation rate (65.5% vs. 42%) compared to CC alone, though pregnancy rate differences were not statistically significant. The study suggests potential benefits of MYO in improving ovulation induction outcomes.", "population_specificity": "26 patients with PCOS eligible for ovulation induction with CC.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:02.365457+00:00"}
{"study_id": 68362, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential use of Myo-inositol (MYO) for treating male infertility, focusing on its antioxidant, prokinetic, and hormonal modulation effects.", "results_summary": "The study suggests MYO may have beneficial effects for male infertility, particularly in cases of asthenozoospermia, due to its antioxidant properties and role in hormonal regulation. A clinical algorithm for MYO use in such patients was proposed.", "population_specificity": "Male infertility patients, specifically those with asthenozoospermia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:02.862629+00:00"}
{"study_id": 68361, "supplement_id": 1223, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the therapeutic potential of inositol in treating hyperandrogenism and metabolic disorders in women with PCOS.", "results_summary": "The study found that inositols act as insulin mimetic agents, improving metabolism and hyperandrogenism in PCOS women without reported side effects. The review highlighted the benefits of inositol in combination with other natural substances for treating PCOS symptoms.", "population_specificity": "Women with polycystic ovary syndrome (PCOS) exhibiting hyperandrogenism and metabolic abnormalities.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:02.981231+00:00"}
{"study_id": 68363, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the immune-modulating effect of myo-inositol combined with seleno-methionine in patients with euthyroid autoimmune thyroiditis (AT).", "results_summary": "The study found that the combined treatment significantly reduced TSH levels, particularly in patients with high-normal baseline TSH, and decreased antithyroid autoantibodies and CXCL10 levels, suggesting a potential reduction in the risk of progression to hypothyroidism.", "population_specificity": "21 newly diagnosed Caucasian patients with euthyroid chronic autoimmune thyroiditis.", "effective_dosage": "600 mg myo-inositol and 83 mg selenium tablets, twice daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:04.081808+00:00"}
{"study_id": 68364, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to compare the therapeutic efficacy of myo-inositol (MYO) versus metformin (MET) in improving hormonal levels, menstrual cycle disorders, and pregnancy rates in women with insulin resistance.", "results_summary": "MYO and MET both significantly improved progesterone and prolactin levels, menstrual cycle disorders, and pregnancy rates, with no significant differences between the two treatments. Combining both treatments yielded slightly better results for fasting serum insulin levels.", "population_specificity": "237 women of reproductive age with insulin resistance symptoms but without diabetes or prediabetes.", "effective_dosage": "4 g myo-inositol plus 400 mcg folic acid per day.", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:04.272909+00:00"}
{"study_id": 68365, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of a mixture containing inositol, beta-glucan, and digestive enzymes in improving gastrointestinal symptoms in IBD-IBS patients.", "results_summary": "The study found that the mixture reduced abdominal pain, bloating, and flatulence, and improved overall well-being in IBD-IBS patients, while conventional treatment alone showed only mild improvement in evacuative urgency.", "population_specificity": "43 IBD patients with IBS symptoms in clinical remission, treated with mesalamine.", "effective_dosage": "One tablet after lunch and dinner (exact inositol dosage not specified).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:05.801147+00:00"}
{"study_id": 68366, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify metabolic differences, including myo-inositol levels, between individuals with multiple sclerosis (MS) and healthy controls to better understand MS pathogenesis and potential biomarkers.", "results_summary": "The study found myo-inositol to be a discriminant metabolite between MS patients and healthy controls, suggesting its potential role as a biomarker for MS. Pathway analysis indicated oxidative stress involvement, but the abstract does not detail specific therapeutic effects of inositol supplementation.", "population_specificity": "Patients with multiple sclerosis (MS) compared to healthy controls (HC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:06.369367+00:00"}
{"study_id": 68367, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "To investigate the effects of D-chiro-inositol (DCI) and Myo-inositol (MI), alone or combined with Revifast\u00ae, on lipid profiles and glucose levels in overweight pregnant women.", "results_summary": "The study found that supplementation with DCI/MI, especially when combined with Revifast\u00ae, significantly improved lipid and glucose parameters compared to placebo, with more pronounced effects at 60 days than at 30 days. Group I (Revifast\u00ae + DCI/MI) showed better outcomes than Group II (DCI/MI alone).", "population_specificity": "Overweight pregnant women with elevated fasting glucose.", "effective_dosage": "Not specified in the abstract.", "study_duration": "30 and 60 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:07.820195+00:00"}
{"study_id": 68368, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to summarize progress in understanding the cellular roles of OCRL, an inositol polyphosphate 5-phosphatase, in regulating phosphoinositide balance and its implications for Lowe syndrome and Dent disease 2.", "results_summary": "The study highlights OCRL's role in phosphoinositide regulation along the endolysosomal pathway, linking mutations in OCRL to Lowe syndrome and Dent disease 2, and discusses the limitations of current animal models.", "population_specificity": "Patients with Lowe syndrome or Dent disease 2, and related animal models.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:10.805881+00:00"}
{"study_id": 68370, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of alpha-actinin-4 (ACTN4) in cancer metastasis, including its mechanosensory regulation and potential therapeutic targeting, with a brief mention of phosphatidyl inositol binding as one of its regulatory mechanisms.", "results_summary": "The abstract highlights that ACTN4 is upregulated in several cancers and exhibits unique mechanosensory regulation compared to \u03b1-actinin-1, mediated by actin-binding affinity and catch-slip-bond behavior. Phosphatidyl inositol binding is noted as one of the shared regulatory mechanisms, but no specific effects of inositol itself are discussed.", "population_specificity": "Metastatic cancer cells and their mechanosensory adaptations in dense tumor stroma.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:12.805969+00:00"}
{"study_id": 68369, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of myo-inositol (MI) combined with non-surgical periodontal therapy on inflammatory and insulin resistance markers in women with PCOS and chronic periodontitis.", "results_summary": "The study found that MI, combined with scaling and root planing (SRP), significantly improved periodontal parameters and reduced hsCRP levels compared to MI alone. Both groups showed significant reductions in HOMA and metabolic parameters, with results comparable to healthy controls by 6 months.", "population_specificity": "Women with polycystic ovary syndrome (PCOS) and chronic periodontitis (n = 60).", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:12.949049+00:00"}
{"study_id": 68372, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effects of inositol as an ovulation induction agent in women with polycystic ovary syndrome (PCOS).", "results_summary": "Inositol significantly improved ovulation rates (RR 2.3; 95% CI 1.1-4.7) and showed benefits for menstrual cycles and metabolic changes in PCOS. The study pooled data from ten randomized trials, suggesting consistent positive effects.", "population_specificity": "Women with polycystic ovary syndrome (PCOS), including those with anovulation and infertility.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:13.522575+00:00"}
{"study_id": 68371, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of the unfolded protein response (UPR), including the involvement of inositol-requiring enzyme-1\u03b1, in cancer cells and tumor-infiltrating myeloid cells under endoplasmic reticulum (ER) stress.", "results_summary": "The abstract discusses the dual pro- and anti-tumorigenic roles of UPR in cancer cells and its impact on immunosuppressive activity in tumor-infiltrating myeloid cells, but does not provide specific results on inositol's effects.", "population_specificity": "Cancer cells and tumor-infiltrating myeloid cells (no human or animal model specified).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:13.748434+00:00"}
{"study_id": 68373, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effects of myo-inositol and metformin on clinical, metabolic, and genetic parameters in women with PCOS.", "results_summary": "Myo-inositol significantly reduced total testosterone, mF-G scores, hs-CRP levels, and IL-1 gene expression compared to metformin, but had no significant effect on other hormonal profiles, NO levels, or IL-8 and TNF-\u03b1 gene expression.", "population_specificity": "Women aged 18-40 with PCOS, including those with hyperinsulinism and normoinsulinism.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:14.143111+00:00"}
{"study_id": 68374, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not focus on Inositol but rather on ROS1 fusion proteins in non-small cell lung cancer and related pathways, including the phosphatidyl inositol 3-kinase pathway.", "results_summary": "The study does not report specific findings about Inositol but mentions the phosphatidyl inositol 3-kinase pathway as part of downstream signaling from ROS1 fusion proteins.", "population_specificity": "Patients with non-small cell lung cancer and other cancers expressing ROS1 fusion proteins.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:14.453686+00:00"}
{"study_id": 68375, "supplement_id": 1223, "safety_score": "90", "efficacy_score": 50, "quality_score": 85, "study_goal": "To evaluate the safety, tolerability, pharmacokinetics, and exploratory efficacy of ELND005 (scyllo-Inositol) in young adults with Down syndrome without dementia.", "results_summary": "ELND005 was well tolerated with no serious adverse events or deaths, achieved measurable blood levels, and showed no significant cognitive or behavioral effects. Pharmacokinetic data indicated dose-dependent accumulation.", "population_specificity": "Young adults with Down syndrome without dementia.", "effective_dosage": "250 mg once daily (QD) or 250 mg twice daily (BID).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:15.182058+00:00"}
{"study_id": 68376, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the clinical efficacy of dietary supplements, including inositol, in children with autism spectrum disorder.", "results_summary": "The study found no significant effect of inositol on clinical aspects of autism in children. The data did not support its efficacy for improving symptoms.", "population_specificity": "Children with autism spectrum disorder.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:17.080020+00:00"}
{"study_id": 68378, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the role of Inositol-trisphosphate 3-kinase A (ITPKA) in tumor growth and metastasis, particularly in lung and breast cancer, and its potential as a biomarker for early detection.", "results_summary": "The study found that ITPKA is overexpressed in various tumor types but not in normal cells, with gene body methylation increasing malignancy. Down-regulation of ITPKA reduced tumor growth and metastasis in lung adenocarcinoma.", "population_specificity": "Lung and breast cancer patients, with a focus on tumor cells versus normal cells.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:20.813157+00:00"}
{"study_id": 68377, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to summarize the biological and pathological roles of GRP78 in female reproductive processes, including its involvement in follicular development, embryo implantation, and placental function.", "results_summary": "The abstract highlights GRP78's critical role in regulating ER stress and its impact on various reproductive processes, suggesting potential therapeutic targets for infertility, but does not specifically address inositol's effects.", "population_specificity": "Female reproductive processes (follicular development, corpus luteum, oviduct, uterus, embryo, preimplantation development, implantation/decidualization, placenta).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:21.721409+00:00"}
{"study_id": 68379, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether an inositol combination administered from the first antenatal visit could prevent gestational diabetes mellitus (GDM) in women with a family history of diabetes.", "results_summary": "The study found that the inositol combination did not prevent GDM, with an incidence of 23.3% in the intervention group compared to 27.5% in the control group, showing no significant difference. Further research is needed to explore varying doses of inositol for GDM prevention.", "population_specificity": "Women with a family history of diabetes, enrolled at their first antenatal visit.", "effective_dosage": "1,100 mg (frequency not specified)", "study_duration": "From first antenatal visit until delivery (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:22.116797+00:00"}
{"study_id": 68382, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of scyllo-inositol as a pharmacological intervention for agitation in Alzheimer's disease patients.", "results_summary": "The abstract mentions that scyllo-inositol shows promise in treating agitation in Alzheimer's disease, though further research is needed to fully determine its safety, tolerability, and efficacy.", "population_specificity": "Patients with Alzheimer's disease experiencing agitation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:22.374302+00:00"}
{"study_id": 68384, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the molecular mechanisms of ER stress-dependent signaling branches, particularly focusing on the role of Inositol-requiring enzyme-1 (IRE1) and other ER transmembrane receptors in the Unfolded Protein Response (UPR).", "results_summary": "The abstract highlights the dual role of UPR branches in adaptive or apoptotic responses to ER stress, with PERK over-activation linked to disease progression. It suggests PERK inhibitors as potential groundbreaking treatments but notes the need for further research to minimize toxicity and side effects.", "population_specificity": "Not specified (review article, not a clinical study)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:23.939058+00:00"}
{"study_id": 68380, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a nutritional intervention including myo-inositol, additional micronutrients, and probiotics could improve maternal glucose tolerance and metabolic outcomes during pregnancy, with potential benefits for infant body composition.", "results_summary": "The study design suggests potential benefits of myo-inositol in maintaining healthy glucose metabolism during pregnancy, but specific efficacy results are not yet reported as the trial is ongoing. The abstract highlights the rationale for myo-inositol's role in enhancing cellular glucose uptake.", "population_specificity": "Women aged 18-38 years planning pregnancy in the UK, Singapore, and New Zealand.", "effective_dosage": "Twice-daily nutritional drink enriched with myo-inositol (exact dosage not specified).", "study_duration": "Up to one year prior to conception, followed through pregnancy and the first year of life.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:24.189167+00:00"}
{"study_id": 68385, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of sperm- and oocyte-derived factors, including inositol trisphosphate receptor (IP3R), in sperm-oocyte binding and oocyte activation.", "results_summary": "The abstract discusses the importance of sperm-derived factors like PLC\u03b6 and oocyte-borne factors such as IP3R in oocyte activation, but does not provide specific results on inositol's effects.", "population_specificity": "Not specified (focus on cellular and molecular mechanisms in sperm-oocyte interaction).", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:24.430112+00:00"}
{"study_id": 68383, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether myo-inositol (MYO) improves pregnancy rates in infertile PCOS patients undergoing controlled ovulation induction and intrauterine insemination (IUI).", "results_summary": "MYO administration increased clinical pregnancy rates (18.6% vs. 12.2%), reduced total rFSH dose, and shortened ovulation induction duration compared to the control group.", "population_specificity": "Infertile patients diagnosed with polycystic ovary syndrome (PCOS) (n=196).", "effective_dosage": "4 g MYO and 400 \u03bcg folic acid before and during ovulation induction.", "study_duration": "Duration of ovulation induction (exact length not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:24.777115+00:00"}
{"study_id": 68386, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether inositol, as an adjunctive treatment with antipsychotics, improves psychiatric symptoms in people with schizophrenia.", "results_summary": "The study found no overall effects of inositol on psychiatric symptoms in people with schizophrenia, based on pooled data from randomized controlled trials.", "population_specificity": "People with schizophrenia", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:28.162219+00:00"}
{"study_id": 68389, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of inositol imbalance in cellular functions and diseases, focusing on its impact on bipolar disorder, Alzheimer's disease, epilepsy, and autophagy.", "results_summary": "The study highlights the regulatory roles of inositol in cellular processes and links its depletion to disease states, using model systems like D. discoideum and S. cerevisiae to translate findings to higher organisms.", "population_specificity": "Model organisms (D. discoideum, S. cerevisiae) and higher model organisms (not specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:30.023020+00:00"}
{"study_id": 68387, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review the potential benefits of inositol as an alternative therapy for excoriation disorder and other body-focused repetitive behaviors.", "results_summary": "The study found that inositol, along with N-acetylcysteine, shows promise in reducing picking behavior, though more research is needed to confirm its efficacy. The review suggests these drugs may be helpful adjunctive treatments.", "population_specificity": "Patients with excoriation disorder and other body-focused repetitive behaviors (e.g., trichotillomania).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:30.165837+00:00"}
{"study_id": 68388, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of calcium dysregulation, including inositol tris-phosphate receptors, in the pathophysiology of Alzheimer's Disease (AD).", "results_summary": "The study found that alterations in calcium dynamics, including exaggerated release from internal stores and anomalies in inositol tris-phosphate receptors, are linked to AD pathology, such as tau phosphorylation and synaptic dysfunction. These changes were observed in both genetic and non-genetic forms of AD.", "population_specificity": "Animal and cell models of AD-causing presenilin mutations, as well as experimental models with AD-like mitochondrial or oxidative stress changes.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:30.376327+00:00"}
{"study_id": 68390, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were reviewing structural and functional information about HDAC inhibitors to explore potential targeting strategies for specific HDAC complexes.", "results_summary": "The abstract discusses the challenges of designing isoform-selective HDAC inhibitors due to structural similarities and highlights the potential of targeting individual HDAC complexes based on recent structural insights.", "population_specificity": "Not specified (theoretical/structural review)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:30.686374+00:00"}
{"study_id": 68391, "supplement_id": 1223, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy and safety of a topical gel containing glycero-phospho-inositol for treating mild to moderate facial seborrheic dermatitis using clinical and digital photography evaluations.", "results_summary": "The study found a significant reduction in desquamation, erythema, and pruritus, with 47.9% of patients showing excellent response (>80% improvement) and no reported local intolerance.", "population_specificity": "25 patients with mild to moderate facial seborrheic dermatitis.", "effective_dosage": "Not specified (applied twice daily as part of a gel formulation).", "study_duration": "45 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:32.079133+00:00"}
{"study_id": 68393, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether D-chiro-inositol (DCI) plus folic acid could improve glucose control and reduce insulin resistance in overweight or obese type 1 diabetes (T1D) patients.", "results_summary": "The study found a significant reduction in HbA1c levels in the DCI-treated group compared to the control group, indicating improved metabolic control. However, no significant changes were observed in BMI or insulin requirements.", "population_specificity": "Overweight or obese type 1 diabetes patients undergoing intensive insulin therapy.", "effective_dosage": "1 g DCI plus 400 mcg folic acid once daily.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:32.726133+00:00"}
{"study_id": 68392, "supplement_id": 1223, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Myo-Inositol combined with other supplements on semen characteristics and DNA fragmentation in men with diagnosed infertility.", "results_summary": "The study found that treatment with Tradafertil (containing Myo-Inositol) significantly improved sperm concentration, progressive motility, and reduced DNA fragmentation compared to placebo, with no reported side effects.", "population_specificity": "Men with previously diagnosed male infertility (oligoasthenoteratozoospermia).", "effective_dosage": "Myo-Inositol 1000 mg, Tribulus Terrestris 300 mg, Alga Ecklonia Bicyclis 200 mg, and Biovis one tablet daily.", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:32.973419+00:00"}
{"study_id": 68397, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 50, "study_goal": "The researchers were evaluating the effectiveness of various treatments, including d-chiro-inositol, for inducing ovulation in women with PCOS.", "results_summary": "The abstract mentions that d-chiro-inositol initially showed promise but later failed as a metabolic treatment for PCOS, indicating inconsistent efficacy.", "population_specificity": "Women with polycystic ovary syndrome (PCOS).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:37.536401+00:00"}
{"study_id": 68395, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the neuroprotective roles of the PI3K/AKT signaling pathway, particularly in relation to serotonin GPCRs, and its potential implications for treating neurodegenerative diseases like Parkinson's.", "results_summary": "The study highlights that the PI3K/AKT signaling pathway exhibits neuroprotective effects, potentially aiding in the survival of dopaminergic neurons, and suggests that food ingredients activating this pathway may offer favorable effects against neurodegenerative diseases.", "population_specificity": "The study focuses on mechanisms relevant to neurodegenerative diseases, particularly Parkinson's disease, but does not specify a human or animal population.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:37.647712+00:00"}
{"study_id": 68394, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of F3/Contactin, a glycosylphosphatidyl inositol-anchored glycoprotein, in hippocampal synaptic plasticity, memory, and potential implications for Alzheimer's disease.", "results_summary": "The study found that F3/Contactin overexpression influenced long-term potentiation, spatial and object recognition memory, and CREB phosphorylation in mice. It also suggested a potential role in modulating neuronal apoptosis and amyloid-beta peptide production, relevant to Alzheimer's disease.", "population_specificity": "Adult and aged transgenic mice overexpressing F3/Contactin.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:38.042818+00:00"}
{"study_id": 68398, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to review the potential of inositol and other nutrients for preventing or treating bronchopulmonary dysplasia (BPD) in preterm infants.", "results_summary": "The abstract does not provide specific findings on inositol's effects, only mentioning it as one of several nutrients under investigation for BPD prevention. Further research is needed to determine its efficacy.", "population_specificity": "Extremely preterm infants at risk of bronchopulmonary dysplasia (BPD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:38.801234+00:00"}
{"study_id": 68399, "supplement_id": 1223, "safety_score": "80", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the efficacy and tolerability of inositol in adults with trichotillomania.", "results_summary": "Inositol did not show significantly greater reductions in trichotillomania symptoms compared to placebo. At study endpoint, 42.1% of patients on inositol were 'much or very much improved' versus 35.3% on placebo.", "population_specificity": "38 adults (35 women; mean age 28.9\u00b111.4) with trichotillomania.", "effective_dosage": "6 to 18 g/day", "study_duration": "10 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:39.357901+00:00"}
{"study_id": 68396, "supplement_id": 1223, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of inositol isoforms (MI and DCI) in managing PCOS, particularly their roles in counteracting insulin resistance and improving ovarian functions.", "results_summary": "The study found that MI and DCI effectively counteract insulin resistance in PCOS, with MI specifically improving ovarian functions and glucose metabolism. Combining MI and DCI in a 40:1 ratio showed promising results, though further research is needed to confirm these findings.", "population_specificity": "Women of reproductive age with polycystic ovary syndrome (PCOS).", "effective_dosage": "MI and DCI combined in a 40:1 ratio (physiological plasma relative amount).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:39.532957+00:00"}
{"study_id": 68400, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of the unfolded protein response (UPR), including inositol-requiring transmembrane kinase 1, in neurodegenerative and psychiatric diseases.", "results_summary": "The study highlights UPR activation in neurodegenerative and psychiatric disorders, suggesting that targeting specific ER stress mediators, including inositol-related pathways, may offer therapeutic potential for these conditions.", "population_specificity": "Neurodegenerative and psychiatric disease models (human, cell lines, and animal models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:40.503963+00:00"}
{"study_id": 68403, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not focus on Inositol but rather examines the role of BTK in B cell receptor signaling and its implications in B cell neoplasms.", "results_summary": "The abstract does not discuss Inositol's effects; it primarily describes BTK's function, its domains (including interaction with phosphatidyl inositol trisphosphate), and the use of ibrutinib in treating B cell lymphomas.", "population_specificity": "Not specified (study is mechanistic, not clinical).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:45.423172+00:00"}
{"study_id": 68402, "supplement_id": 1223, "safety_score": "80", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to assess the safety, tolerability, and efficacy of OXY111A (myo-inositoltrispyrophosphate) as an anti-hypoxic therapy in patients with non-resectable primary and secondary tumors of the liver, pancreas, and biliary tract.", "results_summary": "Preclinical studies showed reduced tumor growth, prolonged survival, and a beneficial side effect profile. The clinical trial is exploratory and aims to validate these findings in human patients.", "population_specificity": "Patients with non-resectable primary and secondary tumors of the liver, pancreas, and biliary tract.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:45.763079+00:00"}
{"study_id": 68404, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to compare metabolic patterns between chronic lesions and normal-appearing white matter (NAWM) in multiple sclerosis (MS) patients, including the assessment of scyllo-inositol levels.", "results_summary": "The study found that NAWM exhibited similar metabolic changes to chronic white matter lesions, with no significant differences in metabolite concentrations (P > 0.07). Scyllo-inositol levels were reliably estimated in averaged spectra, suggesting its presence in both lesion and NAWM tissues.", "population_specificity": "46 patients with relapsing-remitting MS (median disease duration: 0.8 years).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:45.876231+00:00"}
{"study_id": 68406, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of an inositol-enriched beverage on blood glucose levels and inflammation status in subjects with impaired fasting glucose (IFG).", "results_summary": "The study found that the inositol-enriched beverage influenced blood glucose levels and inflammation status in IFG subjects, though specific outcomes are not detailed in the abstract.", "population_specificity": "Subjects with impaired fasting glucose (fasting glucose levels 100-125 mg/dl) categorized by body mass index (BMI).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:46.330930+00:00"}
{"study_id": 68405, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the clinical use of inositol (specifically MYO and DCI) for treating insulin resistance in PCOS patients.", "results_summary": "Preliminary studies suggest potential benefits of inositol therapy for metabolic and hormonal impairments in PCOS, but no meta-analysis has been conducted to confirm these findings. The abstract highlights MYO and DCI as promising alternatives to metformin, though efficacy remains understudied.", "population_specificity": "Polycystic ovary syndrome (PCOS) patients with insulin resistance, independent of obesity status.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:46.501443+00:00"}
{"study_id": 68408, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential of ebselen as a lithium mimetic by inhibiting inositol monophosphatase, suggesting a possible new therapeutic intervention for bipolar disorder.", "results_summary": "The study identified ebselen as a potential lithium mimetic due to its shared ability to inhibit inositol monophosphatase, but noted insufficient data to confirm its efficacy and safety for bipolar disorder.", "population_specificity": "General discussion on bipolar disorder patients, no specific population studied.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:48.144931+00:00"}
{"study_id": 68407, "supplement_id": 1223, "safety_score": "80", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine the chemopreventive effects of myo-inositol in smokers with bronchial dysplasia, focusing on changes in dysplasia rate and related biomarkers.", "results_summary": "Myo-inositol showed a higher complete response rate (26.3% vs. 13.9%) and reduced IL6 levels in BAL, but the overall dysplasia response was not statistically significant (P = 0.76). A significant decrease in PI3K-related gene expression was observed in responders.", "population_specificity": "Smokers with \u22651 site of bronchial dysplasia identified by autofluorescence bronchoscopy-directed biopsy.", "effective_dosage": "9 g once daily for 2 weeks, then twice daily for 6 months.", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:48.690068+00:00"}
{"study_id": 68412, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review synaptic dysfunction, calcium homeostasis, and their implications for neurodegenerative disorders like Huntington disease, not specifically Inositol.", "results_summary": "The abstract does not mention Inositol or its effects, focusing instead on mechanisms of neurodegeneration in Huntington disease.", "population_specificity": "Not specified (abstract discusses Huntington disease generally).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:52.623221+00:00"}
{"study_id": 68413, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate molecular mechanisms underlying lithium-associated renal disease, including the role of inositol monophosphate pathways.", "results_summary": "The study identified molecular alterations in inositol monophosphate and other pathways in lithium-associated nephrogenic diabetes insipidus (NDI), but few studies examined chronic kidney disease (CKD).", "population_specificity": "Pre-clinical studies and limited clinical studies on lithium-associated renal disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:53.385107+00:00"}
{"study_id": 68409, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review major inositol-dependent metabolic pathways and discuss its importance for reproduction.", "results_summary": "The study highlights inositol's role in metabolic pathways and suggests potential benefits for polycystic ovarian syndrome, assisted reproduction, and in vitro fertilization. It also notes inositol deficiency may contribute to insulin resistance and hypothyroidism.", "population_specificity": "General biological context, with specific mentions of follicular fluid, semen, and conditions like polycystic ovarian syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:53.416942+00:00"}
{"study_id": 68411, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of inositol isoforms (myo- and D-chiro-) in improving hormonal and metabolic parameters in women with PCOS, alongside assessing Mediterranean and ketogenic diets as therapeutic strategies.", "results_summary": "The study found that both inositol isoforms effectively improved ovarian function and metabolism in PCOS patients, though firm conclusions were hindered by variability in sample size, dose, and intervention duration across studies. Mediterranean and ketogenic diets also showed promise but require further research.", "population_specificity": "Women with polycystic ovary syndrome (PCOS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:53.701051+00:00"}
{"study_id": 68410, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the therapeutic effect of ligustrazine (not Inositol) combined with holistic nursing on pressure sores and explore its mechanism via the PI3K/AKT pathway.", "results_summary": "Ligustrazine significantly improved the total effective rate and reduced healing time in pressure sore patients. In vitro, it upregulated cell viability and clone formation via PI3K/AKT activation, which was inhibited by LY294002.", "population_specificity": "32 patients with Phase II and Phase III pressure sores.", "effective_dosage": "Not specified for Inositol (study focused on ligustrazine).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:54.116507+00:00"}
{"study_id": 68414, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the biological roles, metabolic pathways, and therapeutic potential of inositol, particularly myo-inositol, in various chronic diseases and cellular processes.", "results_summary": "The study highlights inositol's involvement in multiple cellular processes and its therapeutic potential in gynecological diseases, respiratory stress syndrome, Alzheimer's disease, metabolic syndrome, and cancer, though comprehensive mechanisms remain unclear. Clinical trials show promising results, but further metabolomics-genomic studies are needed.", "population_specificity": "Not specified (broad focus on cellular processes and chronic diseases)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:56.011472+00:00"}
{"study_id": 68415, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of inositol in implicit learning during decision-making, particularly in relation to its biochemical pathways and individual variability.", "results_summary": "High inositol levels were associated with lower decision-making scores during the implicit learning stage of the Iowa Gambling Task, with a large effect size. No associations were found with other compounds, suggesting a specific role for inositol in implicit decision-making processes.", "population_specificity": "54 participants (24 unmedicated depressed patients and 30 healthy individuals).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:10:57.410023+00:00"}
{"study_id": 68416, "supplement_id": 1223, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether inositol supplementation, combined with folic acid, could more effectively prevent neural tube defects (NTDs) than folic acid alone.", "results_summary": "Inositol supplementation prevented spinal and cranial NTDs in mouse models and showed promise in human pilot studies, with no recurrent NTDs observed in 52 pregnancies. Larger trials are needed to confirm efficacy.", "population_specificity": "Women with one or more previous NTD-affected pregnancies (Italy and UK cohorts).", "effective_dosage": "Not specified", "study_duration": "Preconceptionally (duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:00.115829+00:00"}
{"study_id": 68418, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the role of myo-inositol and phosphatidylinositol in metabolic pathways, focusing on thyroid function, autoimmunity, insulin resistance, and related disorders.", "results_summary": "The review highlights the therapeutic potential of myo-inositol in addressing thyroid dysfunction, insulin resistance, metabolic syndrome, PCOS, autoimmunity, and certain malignancies, with promising clinical implications.", "population_specificity": "Not specified (review of experimental and clinical investigations).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:00.689711+00:00"}
{"study_id": 68419, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether ebselen, a lithium-mimetic drug that inhibits inositol monophosphatase, could alter emotional processing and reduce risk-taking behavior in healthy participants.", "results_summary": "Ebselen reduced delay aversion in the Cambridge Gambling Task and increased recognition of positive facial expressions compared to negative ones in the facial emotion recognition task, suggesting decreased impulsivity and a positive emotional bias.", "population_specificity": "20 healthy participants", "effective_dosage": "3600 mg over 24 hours", "study_duration": "24 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:00.980986+00:00"}
{"study_id": 68420, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of ELND005 (scyllo-inositol) as a treatment for agitation in persons with dementia, based on subgroup analysis and biomarker data.", "results_summary": "The study identified ELND005 as a candidate progressing to phase III development, suggesting potential efficacy for agitation in dementia, though detailed results were not provided in the abstract.", "population_specificity": "Persons with dementia experiencing agitation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:01.265191+00:00"}
{"study_id": 68417, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of ciliary genes in obesity, focusing on their potential involvement in adipogenesis, neuronal food intake regulation, and food odour perception.", "results_summary": "The study found that variations in cilia-related genes may contribute to obesity as part of a multifactorial etiology, with genotype-phenotype relationships observed. Obesity severity and onset age varied depending on the specific ciliary gene involved, with basal cilium activities being more linked to obesity than intraflagellar transport itself.", "population_specificity": "Not specified (general review of ciliopathies with obesity as a symptom)", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:01.768344+00:00"}
{"study_id": 68421, "supplement_id": 1223, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a combination of Boswellia, betaine, and myo-inositol could effectively reduce fibroadenoma volume in young women.", "results_summary": "The study found that the experimental group (receiving Boswellia, betaine, and myo-inositol) showed a significant median volume reduction of 17.86% in fibroadenoma compared to 5.96% in the placebo group, with 38.88% of patients experiencing volume reduction versus 17.85% in the placebo group. No relevant side effects were reported.", "population_specificity": "Young women aged \u2264 30 years with fibroadenoma.", "effective_dosage": "Not specified (combination therapy included Boswellia, betaine, myo-inositol, B-group vitamins, and N-acetylcysteine).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:05.786979+00:00"}
{"study_id": 68422, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of the PI3-K/AKT pathway in radioresistance and investigate HIV protease inhibitors (like nelfinavir) as potential radiosensitizers by targeting this pathway.", "results_summary": "The study found that blocking the PI3-K/AKT pathway enhances radiation response in tumor cells, and HIV protease inhibitors (HPIs) like nelfinavir show promise as radiosensitizers in vitro and in vivo. HPIs are being investigated alongside chemotherapeutic drugs to overcome radioresistance in various malignancies.", "population_specificity": "Tumor cells (in vitro and in vivo) and clinical trials for different malignancies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:06.388901+00:00"}
{"study_id": 68424, "supplement_id": 1223, "safety_score": "80", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Inositol as an adjunctive treatment for depression.", "results_summary": "The study found nonsignificant results for Inositol, indicating it did not show a meaningful effect in reducing depressive symptoms. No major adverse effects were noted, aside from minor digestive disturbances.", "population_specificity": "Patients with depression receiving adjunctive nutrient therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:07.893048+00:00"}
{"study_id": 68425, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the role of ion channels, including big-conductance Ca, in regulating contractile responses in urinary bladder smooth muscle cells (UBSMCs).", "results_summary": "The abstract does not provide specific findings regarding Inositol's effects, only mentioning the regulation of UBSMC contractions by ion channels.", "population_specificity": "Urinary bladder smooth muscle cells (UBSMCs)", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:08.396331+00:00"}
{"study_id": 68426, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the correlation between ER stress and liver disease, focusing on potential therapeutic targets, including pathways involving inositol-requiring enzyme-1\u03b1 (IRE1\u03b1).", "results_summary": "The abstract discusses the role of UPR signaling pathways, including IRE1\u03b1, in liver disease but does not provide specific findings on Inositol's effects. It highlights potential opportunities for novel therapeutic strategies targeting these pathways.", "population_specificity": "Not specified (general focus on liver disease mechanisms)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:09.380392+00:00"}
{"study_id": 68427, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine if pioglitazone increases insulin-stimulated release of the DCI-IPG second messenger in women with PCOS.", "results_summary": "Pioglitazone treatment increased insulin-stimulated release of DCI-IPG, suggesting a potential mechanism for its insulin-sensitizing effects in women with PCOS.", "population_specificity": "32 women with PCOS at a tertiary referral center in Venezuela.", "effective_dosage": "Pioglitazone 45 mg daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:09.680858+00:00"}
{"study_id": 68423, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the roles of myo-inositol and D-chiro-inositol in insulin-dependent processes, particularly in polycystic ovary syndrome (PCOS), and their synergistic effects when combined in a physiological ratio.", "results_summary": "Myo-inositol positively affects ovarian and non-ovarian pathways, while D-chiro-inositol primarily benefits non-ovarian tissues by mitigating hyperinsulinemia effects. Combining both isomers in a 40:1 ratio shows synergistic, multi-targeted benefits for PCOS management.", "population_specificity": "Patients with polycystic ovary syndrome (PCOS).", "effective_dosage": "Physiological plasma ratio of 40:1 (myo-inositol to D-chiro-inositol).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:09.954791+00:00"}
{"study_id": 68429, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize recent advances regarding the roles of STIM-ORAI and IP3Rs in calcium-dependent signaling processes and their implications in tumorigenesis and tumor progression.", "results_summary": "The study found that STIM-ORAI and IP3Rs are dysregulated in cancer, promoting cell proliferation, apoptosis evasion, and migration through calcium signaling. Understanding these mechanisms may offer new pharmacologic targets for cancer therapy.", "population_specificity": "Malignant cancer cells (in vitro or theoretical context, not specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:15.283233+00:00"}
{"study_id": 68430, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review clinical and molecular genetic findings in Lowe syndrome and the cellular and physiological functions of OCRL-1, which involves inositol polyphosphate 5-phosphatase activity.", "results_summary": "The study highlights that OCRL-1, an enzyme related to inositol metabolism, is involved in intracellular processes like endocytic trafficking and actin skeleton dynamics, explaining multi-organ manifestations in Lowe syndrome and Dent-2 disease. However, the mechanisms behind the phenotypic spectrum remain unclear, and no causative therapy exists.", "population_specificity": "Patients with Lowe syndrome or Dent-2 disease (rare X-linked disorders).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:16.123925+00:00"}
{"study_id": 68431, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the role of immunoreceptors in regulating neutrophil effector functions, including signaling pathways involving inositol lipids.", "results_summary": "The study found that immunoreceptors in neutrophils commonly signal via conserved ITAM or ITIM motifs, which depend on phosphorylation of inositol lipids, contributing to balanced homeostatic regulation of neutrophil functions. Some of these pathways are targeted by pathogens or explored for therapeutic intervention.", "population_specificity": "Not specified (general review of neutrophil biology)", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:16.536933+00:00"}
{"study_id": 68433, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of inositol supplementation in reducing the incidence of retinopathy of prematurity (ROP) in neonates.", "results_summary": "Inositol supplementation was found to be beneficial in reducing ROP incidence, but this effect was only observed in observational studies and not replicated in randomized trials.", "population_specificity": "Neonates born at <32 weeks gestation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:16.673122+00:00"}
{"study_id": 68434, "supplement_id": 1223, "safety_score": "85", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of myo-inositol (MI) and D-chiro-inositol (DCI) in counteracting insulin resistance-related metabolic alterations in conditions like metabolic syndrome, type II diabetes, and polycystic ovarian syndrome.", "results_summary": "The study found that MI and DCI act as insulin sensitizers, complementing each other's metabolic actions and synergizing with other insulin-sensitizing drugs or nutraceuticals. However, methodological biases across studies highlight the need for further research on outcomes and optimal dosages.", "population_specificity": "Patients with metabolic syndrome, type II diabetes, and polycystic ovarian syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:18.319530+00:00"}
{"study_id": 68432, "supplement_id": 1223, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to assess the effect of the SHIP1 activator AQX-1125 (related to inositol metabolism) on bladder pain and urinary symptoms in patients with interstitial cystitis/bladder pain syndrome.", "results_summary": "AQX-1125 significantly reduced bladder pain and improved urinary symptoms compared to placebo, with notable decreases in pain scores and urinary frequency. Adverse event rates were similar between AQX-1125 and placebo, and no serious adverse events were reported.", "population_specificity": "Women with moderate to severe interstitial cystitis/bladder pain syndrome and a mean pain score of 5 or greater despite treatment.", "effective_dosage": "Once daily oral administration (specific dosage not mentioned in abstract).", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:18.493866+00:00"}
{"study_id": 68437, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine if Inositol could reduce the incidence of gestational diabetes mellitus (GDM) in high-risk pregnant women.", "results_summary": "The abstract suggests that Inositol may help reduce GDM incidence in high-risk pregnant women, though specific results or statistical significance are not detailed.", "population_specificity": "High-risk pregnant women", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:23.005620+00:00"}
{"study_id": 68435, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers sought to determine whether reduced endoplasmic reticulum calcium levels and inositol-1,4,5-trisphosphate (InsP3)-dependent calcium transfer contribute to apoptosis resistance in renal cellular carcinoma-derived endothelial colony forming cells (RCC-ECFCs).", "results_summary": "The study found that RCC-ECFCs exhibited lower endoplasmic reticulum calcium levels and impaired InsP3-dependent mitochondrial calcium uptake, which was associated with ER stress and reduced sensitivity to apoptosis-inducing agents. Buffering intracellular calcium levels further dampened apoptosis, suggesting a survival advantage linked to ER calcium underfilling in these cells.", "population_specificity": "Renal cellular carcinoma-derived endothelial colony forming cells (RCC-ECFCs)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:24.729308+00:00"}
{"study_id": 68436, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of calcium signaling and ion channels in stem cell differentiation and proliferation, particularly in the context of neurodegenerative diseases.", "results_summary": "The study found that calcium signaling is crucial for stem cell differentiation and that ion channel expression varies based on cell type and differentiation conditions, suggesting intrinsic mechanisms drive functional properties of differentiated cells.", "population_specificity": "Human embryonic stem cells (hESCs), human induced pluripotent stem cells (hiPSCs), and mesenchymal stem cells from rats.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:24.905782+00:00"}
{"study_id": 68439, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of sperm-specific phospholipase C (PLC\u03b6) in triggering calcium oscillations in mammalian eggs and its potential therapeutic use in infertility treatments.", "results_summary": "The study found that PLC\u03b6 triggers calcium oscillations in eggs, mimicking fertilization, and is more potent than other PLCs. It suggests PLC\u03b6 could improve egg activation and early embryo development in IVF treatments.", "population_specificity": "Mammalian eggs (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:25.502102+00:00"}
{"study_id": 68440, "supplement_id": 1223, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review progress and future directions for developing novel molecules to study and manipulate the cellular actions of inositol pyrophosphates (PP-IPs).", "results_summary": "The abstract discusses the potential of chemical probes, including inhibitors and mimics, to investigate PP-IPs but does not report specific findings on inositol's effects.", "population_specificity": "Not specified (review of molecular research).", "effective_dosage": "Not available.", "study_duration": "Not applicable (review paper).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:11:25.641314+00:00"}
